WO2022068550A1 - Venous valve stent and venous valve prosthesis - Google Patents

Venous valve stent and venous valve prosthesis Download PDF

Info

Publication number
WO2022068550A1
WO2022068550A1 PCT/CN2021/117438 CN2021117438W WO2022068550A1 WO 2022068550 A1 WO2022068550 A1 WO 2022068550A1 CN 2021117438 W CN2021117438 W CN 2021117438W WO 2022068550 A1 WO2022068550 A1 WO 2022068550A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
venous valve
sinus cavity
strut
valve
Prior art date
Application number
PCT/CN2021/117438
Other languages
French (fr)
Chinese (zh)
Inventor
王永胜
郭伟
李建民
Original Assignee
杭州诺谊医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202011049137.8A external-priority patent/CN114305795A/en
Priority claimed from CN202022196520.8U external-priority patent/CN212234805U/en
Application filed by 杭州诺谊医疗科技有限公司 filed Critical 杭州诺谊医疗科技有限公司
Publication of WO2022068550A1 publication Critical patent/WO2022068550A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body

Definitions

  • the invention relates to the technical field of medical devices, in particular to a venous valve stent and a venous valve prosthesis.
  • Venous surgery disease is a common disease in surgery, which mostly occurs in the lower extremities. Its main clinical manifestations are varicose veins, limb swelling, and skin dystrophic lesions in the boot area, such as dermatitis, pigmentation, and ulceration.
  • the main pathological reason is that the venous valve loses the basic function of one-way opening under the action of pathogenic factors. Mild cases of venous disease hinder the ability to live and work, and severe cases can cause different degrees of disability. Therefore, the treatment of lower extremity venous valve disease has received increasing attention. At present, most of the clinical treatment of the disease is still conservative, such as drug therapy, pressure pump, etc., and surgical treatment such as femoral vein valve repair and reconstruction, etc., the clinical effect is not ideal. Especially in patients with severely damaged venous valves or congenital avalvular disease, venous valve transplantation seems to be the only option.
  • the autologous valved iliac vein prosthesis or popliteal vein prosthesis is often used in clinic.
  • the prosthesis is implanted into the venous blood vessel, and the stent of the prosthesis is attached to the blood vessel.
  • the valve can open or close the channel to achieve a one-way opening function.
  • local thrombus is easily formed between the valve and the stent, and the valve is also prone to degeneration and insufficient anti-reflux capability. In the long run, the effect is not ideal.
  • the purpose of the present invention is to provide a venous valve stent and a venous valve prosthesis with better reliability.
  • the present invention adopts the following technical solutions:
  • the present invention provides a venous valve stent, comprising a stent body and at least one sinus cavity frame; the stent body has a hollow cylindrical structure and can be radially expanded and contracted; the side portion of the stent body is provided with at least one fenestration; at least one sinus cavity frame is arranged corresponding to the at least one fenestration; each sinus cavity frame has opposite fixed ends and free ends; the fixed end is connected to a corresponding edge of the fenestration; the The free end is suspended; at least part of the sinus cavity frame protrudes outward from the stent body in the radial direction of the stent body; the inner side of the sinus cavity frame forms a sinus area, and the sinus area passes through the opening.
  • the window communicates with the inside of the bracket body.
  • the free end does not extend beyond the outermost portion of the rest of the sinus cage except the free end.
  • the sinus lumen frame includes a first extension section and a second extension section, the second extension section is connected to the stent body through the first extension section, and the first extension section is connected to the stent body.
  • the part where the second extension is connected forms the outermost part of the sinus cavity frame, the end of the second extension forms the free end, and the part where the first extension is connected with the stent body forms the fixing
  • the distance between the outermost part and the central axis of the bracket body is greater than the distance between the fixed end and the central axis of the bracket body.
  • the distance between the free end and the central axis of the stent body is smaller than the distance between the outermost portion and the central axis of the stent body.
  • the second extension section extends in a curved line, and the curved line protrudes in a direction away from the bracket body.
  • the second extension segment extends linearly.
  • the projection of the second extension on the plane is parallel to the central axis.
  • the first extension section extends in a curved shape, and the curved line protrudes in a direction away from the bracket body.
  • the first extension segment extends linearly.
  • the sinus cavity rack includes a first strut and a second strut connected to the first strut, the first strut and the second strut are respectively connected to the stent body,
  • the fixed end is formed at the part where the first support rod and the second support rod are connected to the bracket body respectively; the free end is formed at the connection part of the first support rod and the second support rod.
  • first strut and the second strut are directly connected.
  • the sinus cage further includes a cross bar through which the first strut and the second strut are connected.
  • the part where the first strut and the bracket body are connected in the direction from the first end to the second end, is connected to the second strut and the bracket body.
  • the distance between the parts is greater than the distance between the part where the first support rod and the cross rod are connected and the part where the second support rod and the cross rod are connected.
  • the included angle between the first strut and the second strut is 30° ⁇ 90°.
  • first strut and the second strut are symmetrical.
  • At least one of the fenestrations is located in an axially central region of the stent body.
  • the length of the sinus cage in the axial direction of the stent body is greater than half the length of the corresponding fenestration in the axial direction of the stent body.
  • the bracket body includes at least two supporting bodies and a plurality of uprights, each of the uprights is connected to two of the supporting bodies at intervals, and the window is enclosed by the supporting bodies and the uprights become.
  • each of the supporting bodies includes a plurality of wave circles that are connected in the axial direction; each wave circle has staggered wave crests and wave troughs along the circumferential direction, and in two adjacent wave circles, one of the wave circles is The peaks of the wave circles are connected with the valleys of the other wave circles to form a grid.
  • the peaks of one of the supports are connected to the troughs of the other support through the posts.
  • the uprights are linear and extend along the axial direction of the stent body.
  • the bracket body is an integral structure, the entire outer peripheral wall thereof is in the shape of a mesh, and at least one of the openings is defined on the outer peripheral wall.
  • the number of the fenestrations is multiple, and the multiple fenestrations are distributed along the circumference of the stent body; the sinus cavity frame is provided with a plurality of fenestrations, which are connected to the fenestrations in one-to-one correspondence. edge.
  • the present invention provides a venous valve prosthesis, comprising a valve and the above-mentioned venous valve stent; the valve is fixed in the stent body, and the valve is connected to the sinus cavity frame. At least partially opposite in the radial direction of the stent body; the valve has a free edge on the side of the valve facing away from the sinus region.
  • the venous valve prosthesis further comprises a membrane covering the entire peripheral wall of the venous valve stent.
  • the present invention has at least the following advantages and positive effects: in the venous valve stent of the present invention, the stent body is a radially retractable cylindrical structure, so the venous valve stent can be in a contracted state before being implanted in the human body. It is accommodated in the delivery catheter, so that it can be delivered into the vein using the delivery catheter, and the surgical incision is small. After being implanted into the human body, the stent body is radially expanded and anchored in the blood vessel through self-expansion. The stent body can build a channel for blood to pass through, and can cooperate with the valve loaded in the venous valve stent to reconstruct the single venous valve. To guide function, and prevent venous blood reflux.
  • the venous valve stent has a sinus cavity frame that protrudes outward relative to the stent body, and a sinus area is formed inside the sinus cavity frame.
  • the venous valve stent is loaded with a valve that can create eddy currents in the sinus region when blood flows back. Based on the vortex formed in the sinus area, when the blood flows downstream, the force of the downstream blood on the valve is balanced with the pressure generated by the vortex, so that the valve leaflet of the valve can be suspended without contacting the venous valve stent, reducing the stickiness of the valve leaflet.
  • the backflowing blood impinges on the valve leaflets in suspension, which can more easily deform the valve leaflets in the direction of closing the blood flow channel, and quickly causes the valve leaflets to be deformed in the direction of closing the blood flow channel rather than impacting the valve leaflets that fit the venous valve stent. Close the channel to improve the sensitivity and reliability of the one-way open function.
  • the regurgitated blood can be guided to flow toward the heart again, which can effectively avoid the accumulation of blood and reduce the risk of local thrombosis.
  • the free end of the sinus cavity frame is suspended, so that the sinus cavity frame is elastic in the radial direction, which can avoid excessive stimulation of the blood vessel by the sinus cavity frame, reduce damage to the blood vessel, and prevent excessive intimal hyperplasia of the blood vessel.
  • the sinus cavity frame is connected to the fenestration edge of the stent body through its fixed end, and the structure and shape of the sinus cavity frame is not constrained by the stent body, which is convenient for the manufacture of the sinus cavity frame and the connection with the stent body. Afterwards, it is also convenient to maintain the structural form of the sinus cavity frame protruding from the stent body so as to maintain the stability of the sinus area.
  • FIG. 1 is a schematic structural diagram of the first embodiment of the venous valve prosthesis of the present invention.
  • FIG. 2 is a front view of FIG. 1 .
  • FIG. 3 is a plan view of FIG. 1 .
  • FIG. 4 is a schematic view of the structure of FIG. 1 after removing the thin film.
  • FIG. 5 is a front view of the venous valve stent of FIG. 1 .
  • FIG. 6 is a side view of FIG. 5 .
  • FIG. 7 and FIG. 8 are schematic cross-sectional views of FIG. 1 after implantation in a human blood vessel, and the figures illustrate the open and closed states of the valve, respectively.
  • FIG. 9 is a schematic structural diagram of the second embodiment of the venous valve prosthesis of the present invention.
  • FIG. 10 is a plan view of FIG. 9 .
  • FIG. 11 is a schematic diagram of the internal structure of FIG. 9 .
  • FIG. 12 is a schematic structural diagram of the venous valve stent in FIG. 9 .
  • Fig. 13 is a schematic structural diagram of the third embodiment of the venous valve prosthesis of the present invention.
  • FIG. 14 is a plan view of FIG. 13 .
  • Fig. 15 is a schematic structural diagram of the fourth embodiment of the venous valve prosthesis of the present invention.
  • FIG. 16 is a schematic structural diagram of the venous valve stent in FIG. 15 .
  • FIG. 17 is a schematic structural diagram of the fifth embodiment of the venous valve prosthesis of the present invention.
  • FIG. 18 is a front view of FIG. 17 .
  • Fig. 19 is a schematic structural diagram of the sixth embodiment of the venous valve prosthesis of the present invention.
  • FIG. 20 is a side view of the venous valve stent of FIG. 19 .
  • FIG. 21 is a front view of FIG. 20 .
  • Fig. 22 is a schematic structural diagram of the seventh embodiment of the venous valve prosthesis of the present invention.
  • FIG. 23 is a front view of FIG. 22 .
  • 100/100a/100b/100c/100d/100e/100f venous valve prosthesis
  • 500 blood vessel
  • 11/11a/11c/11d/11e/11f stent body; 111/111e, support body; 1111/1111f, wave circle; 1115, crest; 1116, trough; 1112, developing rod; 112/112a/112b/112e, Column; 115/115f, window opening;
  • valve 2/2a/2b, valve; 201, fixed edge; 202/202a, free edge; 21, valve body; 22, leaflet;
  • the invention provides a venous valve stent and a venous valve prosthesis, which are used for the interventional treatment of venous valve insufficiency.
  • the venous valve prosthesis includes the venous valve stent and a valve connected within the venous valve stent.
  • the venous valve prosthesis is delivered into the diseased vein by means of percutaneous puncture through a delivery catheter, and is precisely positioned and released, so as to prevent venous blood backflow.
  • proximal refers to the end close to the location of the heart
  • distal refers to the end that is remote from the location of the heart.
  • the normal direction of blood flow in human veins is toward the heart, that is, from the distal end to the proximal end.
  • the venous valve prosthesis 100 of this embodiment includes a venous valve stent 1 , a valve 2 and a membrane 3 .
  • the venous valve stent 1 is a bare stent, which forms a channel 101 for blood to pass through the distal end and the proximal end in the unfolded state.
  • the side of the venous valve stent 1 is also formed with a convex sinus region 102 .
  • the film 3 can be sutured, bonded or thermocompressed on the inner side of the venous valve stent 1, or can be sutured, bonded or thermocompressed on the outside of the venous valve stent 1, covering the entire peripheral wall of the venous valve stent 1, the film 3 and the venous valve stent 1.
  • the valve stent 1 is combined into a whole, so as to increase the contact area between the venous valve prosthesis 100 and the human blood vessel.
  • the valve 2 is a single-valve structure, located inside the venous valve stent 1 , connected and fixed with the venous valve stent 1 , and covers at least part of the sinus region 102 to function as one-way conduction.
  • the venous valve stent 1 includes a stent body 11 and a sinus cavity frame 12 connected to the side of the stent body 11 .
  • the bracket body 11 has a hollow cylindrical structure as a whole, so a channel 101 can be formed in its interior.
  • a fenestration 115 is provided on the side of the stent body 11; the sinus cavity frame 12 is connected to the edge of the fenestration 115 and protrudes radially outward relative to the stent body 11, thereby forming the sinus region 102 inside the sinus cavity frame 12, The sinus region 102 communicates with the channel 101 inside the stent body 11 through the fenestration 115 .
  • the bracket body 11 of this embodiment mainly includes two supporting bodies 111 arranged at intervals and a plurality of uprights 112 connected between the two supporting bodies 111 .
  • the support body 111 is a self-expanding structure, and is in the shape of a cylindrical closed-loop in the circumferential direction.
  • the two support bodies 111 are arranged coaxially and are opposite to each other along the axial direction.
  • Each support body 111 has a plurality of wave rings 1111 axially connected to each other.
  • Each wave circle 1111 has crests 1115 and troughs 1116 that are staggered in the circumferential direction.
  • the crest 1115 is toward the proximal end, and the trough 1116 is toward the distal end.
  • the crests 1115 and troughs 1116 of two adjacent wave circles 1111 are connected to form a grid.
  • each wave ring 1111 can be close to or away from each other, so that the support body 111 and the entire stent body 11 can expand and contract in the radial direction.
  • the stent body 11 is in a contracted state before being implanted into the human body to be accommodated in the delivery catheter, and after being implanted into the human body, it expands and anchors at a predetermined position of the human blood vessel through self-expansion.
  • the anchoring is mainly achieved by combining the support body 111 with the human blood vessel after radial expansion.
  • each support body 111 has two corrugated circles 1111 .
  • Each wave ring 1111 can be regarded as a closed-loop structure extending in a Z-shape from a rod.
  • Each wave circle 1111 has eight wave crests 1115 and eight wave troughs 1116 arranged in a circumferentially staggered manner.
  • the wave troughs 1116 of the wave ring 1111 at the proximal end are connected with the wave crests 1115 of the wave ring 1111 at the far end, forming eight successively connected diamond-shaped grids along the circumferential direction of the support body 111 .
  • the two wave rings 1111 form a circumferential closed-loop structure, so that the venous valve stent 1 has high radial support force and better anchoring effect.
  • Two developing rods 1112 protrude from the support body 111 located at the proximal end toward the proximal end, and two developing rods 1112 protrude toward the distal end from the support body 111 located at the distal end.
  • the two developing rods 1112 on each supporting body 111 are circumferentially opposite, and the four developing rods 1112 are staggered circumferentially.
  • a developing mark can be set on the developing rod 1112 to facilitate displaying the position of the venous valve stent 1 during implantation.
  • the developing mark is set on the developing rod 1112 by using developing material, and can be set in a dot shape, a line shape, or the like.
  • the end of the developing rod 1112 is annular, which can be used for pressing dot-shaped developing marks.
  • Each of the uprights 112 is linear and extends along the axial direction of the bracket body 11 .
  • the plurality of uprights 112 are circumferentially spaced around the central axis L of the support body 111 .
  • the cylindrical structure formed by the plurality of uprights 112 is coaxial with the support body 111 .
  • Two ends of the upright column 112 are respectively connected with the wave crests 1115 and the wave troughs 1116 opposite to the two support bodies 111 . That is, the proximal end of the upright post 112 is connected to the trough 1116 of the proximal support body 111 , and the distal end of the upright post 112 is connected to the corresponding wave crest 1115 of the distal support body 111 .
  • the number of the uprights 112 is four, which are evenly arranged in the circumferential direction between the two support bodies 111 , and one upright post 112 is connected every at least one wave crest 1115 or wave trough 1116 along the circumferential direction.
  • the interval between two adjacent uprights 112 forms a window 115 , and the distance between the two supports 111 or the length of the uprights 112 constitutes the axial length of the window 115 .
  • the structure of the stent body 11 can provide good radial support force by using the support bodies 111 located at both ends in a closed-loop structure, and has the advantage of strong anchoring force, which is convenient for fitting and fixing with human blood vessels.
  • the upright post 112 in the middle increases the axial rigidity of the venous valve stent 1 , which facilitates the venous valve stent 1 to maintain the stability of the shape.
  • the width of the upright post 112 is greater than the width of the rod of the wave ring 1111 of the support body 111 .
  • the sinus cavity frame 12 is correspondingly connected to the opening 115 of the stent body 11 .
  • the sinus frame 12 includes a first strut 121 and a second strut 122 .
  • the first end, ie, the distal end, of the first support rod 121 is separated from the first end, ie, the distal end, of the second support rod 122 , and each is connected to a post 112 that defines the window 115 .
  • the second end, ie, the proximal end, of the first strut 121 is connected to the second end, ie, the proximal end, of the second strut 122, and forms a free end 1203 of the sinus frame 12; the free end 1203 is overhanging from the The outer side of the bracket body 11 .
  • the space enclosed between the first strut 121 , the second strut 122 and the two uprights 112 to which they are connected forms the sinus area 102 .
  • the first strut 121 and the second strut 122 gradually approach each other.
  • the proximal end of the first support rod 121 and the proximal end of the second support rod 122 are directly connected, and the first support rod 121 and the second support rod 122 are connected to form a V-shape.
  • the first support rod 121 and the second support rod 122 are symmetrical.
  • the included angle ⁇ formed by the first support rod 121 and the second support rod 122 preferably ranges from 30° to 90°.
  • the distal ends of the first support rod 121 and the second support rod 122 are respectively connected to the distal ends of the two uprights 112 , so that the first support rod can be held by the radial support force of the support body 111 .
  • the relative position of the rod 121 and the second support rod 122 is respectively connected to the distal ends of the two uprights 112 , so that the first support rod can be held by the radial support force of the support body 111 .
  • the sinus cavity frame 12 starts at the distal end of the post 112, and then extends proximally beyond the midpoint of the post 112, but is different from the one located at the proximal end. There is a space between the support bodies 111 . That is, the length of the sinus cavity frame 12 in the axial direction of the stent body 11 is greater than half of the axial length of the fenestration 115 , which is convenient for guiding the flow of blood and also facilitating the arrangement of the membrane 3 .
  • the sinus cavity frame 12 relative to the stent body 11 gradually extends outwardly and then gradually inwardly. That is, the free end 1203 of the sinus cavity frame 12 is bent toward the inner side of the stent body 11 , so that the free end 1203 of the sinus cavity frame 12 does not exceed the outermost part 1204 of the sinus cavity frame 12 along the radial direction of the stent body 11 . , which can effectively prevent the free end 1203 of the sinus cavity frame 12 from damaging the vascular tissue when implanted into a human blood vessel.
  • the sinus cavity frame 12 is divided into a first extension section 1201 near the distal end and a second extension section 1202 near the proximal end.
  • the distance Di from each position of the first extension section 1201 to the central axis L of the stent body 11 gradually increases, and the distance from each position of the second extension section 1202 to the central axis L of the stent body 11 Dj gradually decreases.
  • the distal end of the first extension section 1201 is connected to the stent body 11, and the part where the first extension section 1201 and the second extension section 1202 are connected constitutes the outermost part 1204 of the sinus frame 12 relative to the stent body 11.
  • the second extension The end of the segment 1202 is the free end 1203 .
  • the sinus cavity frame 12 is curved in an arc shape as a whole, so that the sinus cavity frame 12 will not form an obvious bending edge or a bending edge at the junction of the first extension section 1201 and the second extension section 1202, which can further prevent When implanted into a human blood vessel, the sinus cavity scaffold 12 damages the blood vessel tissue.
  • the outer diameter of the support body 111 of the stent body 11 is D1
  • the distance between the outermost part 1204 of the sinus cavity frame 12 and the side wall on the opposite side of the support body 111 is D2 , D2>D1.
  • the difference between D2 and D1 is the maximum distance that the sinus cavity frame 12 protrudes outward.
  • the increasing speed of the distance from the first extending section 1201 to the central axis L gradually decreases, while the distance between the second extending section 1202 and the central axis L decreases the speed. gradually become larger.
  • the first support rod 121 and the second support rod 122 are both curved in the range of the first extension section 1201 and the range of the second extension section 1202 , and the curves of the first extension section 1201 and the second extension section 1202 are curved. Both are protruding in the direction away from the bracket body 11 , which can improve the deformation resistance of the first support rod 121 and the second support rod 122 . And when implanted into a human blood vessel, the bending directions of the first strut 121 and the second strut 122 are both protruding toward the blood vessel, and the first strut 121 and the second strut 122 can withstand greater damage caused by the blood vessel wall. The radial pressure is easy to maintain the stability of the shape.
  • the first extension section 1201 and the second extension section 1202 may also both extend in a straight line, and in the direction from the distal end to the proximal end, the first extension section 1201 reaches the central axis L The increasing speed of the distance remains unchanged, and the decreasing speed of the distance between the second extension section 1202 and the central axis L also remains unchanged. That is, the first support rod 121 and the second support rod 122 are both straight-section structures in the range of the first extension section 1201 and the range of the second extension section 1202 .
  • the second extension section 1202 may extend in a straight line.
  • the second extension section 1202 may also extend in a curve shape.
  • the structure of the sinus cavity frame 12 in this embodiment is simple and easy to manufacture.
  • the number of structural parts of the sinus cavity frame 12 is small, and the metal coverage rate is small, so as to avoid intimal hyperplasia caused by excessive stimulation of human blood vessels.
  • a vortex can be formed in the sinus region 102 when the blood flows back, which is beneficial to the pressure balance of the valve 2 .
  • the valve 2 is located in the stent body 11 of the venous valve stent 1 , aligned with the sinus cavity frame 12 , and covers at least a part of the sinus region 102 . At least part of the valve 2 and the sinus cavity frame 12 are opposite to each other in the radial direction of the stent body 11 , that is, there is at least one cross section perpendicular to the central axis of the stent body 11 which passes through the valve 2 and the sinus cavity frame 12 at the same time.
  • the valve 2 has a substantially V-shaped fixing edge 201, and the fixing edge 201 is fixed to the stent body 11 or the membrane 3 by, for example, suturing or bonding.
  • the V-shaped apex of the fixed edge 201 is located on the side where the sinus cavity frame 12 is located, is close to the sinus cavity frame 12, and is closer to the distal end relative to the sinus cavity frame 12.
  • the V-shaped apex of the fixed edge 201 can be fixed at the distal end.
  • the wave crest 1115 is located between the two uprights 112 to which the sinus cavity frame 12 is connected.
  • the fixed edge 201 starts from the apex of the V shape and extends obliquely along the inner wall of the stent body 11 toward the opposite side to the proximal end of the sinus cavity frame 12, so that if shown in FIG. 2 From the front view of (the valve 2 is obscured and not shown in FIG. 2 ), the valve 2 covers a portion of the sinus region 102 .
  • the length of the valve 2 in the axial direction of the stent body 11 may be, for example, beyond the sinus cavity frame 12 .
  • the side of the valve 2 facing away from the sinus cavity frame 12 is not fixed with the stent body 11 , so a free edge 202 is formed, and both ends of the free edge 202 are connected to the V-shaped opening of the fixed edge 201 .
  • the valve 2 can close or open the channel 101 in the stent body 11 .
  • the blood When the blood flows from the proximal end to the distal end of the channel 101, the blood passes through the sinus region 102 and pushes the valve 2 to the inner wall of the stent body 11 on the opposite side of the sinus cavity frame 12, so that the free edge 202 of the valve 2 and the membrane on the stent body 11 are connected. 3, the blood will not be able to flow further distally through the valve 2, and the channel 101 is closed.
  • the blood will push the valve 2 to the side where the sinus region 102 is located, at this time, the free edge 202 of the valve 2 is separated from the membrane 3, and the channel 101 is opened.
  • valve 2 when the valve 2 is pushed to the inner wall of the stent body 11 on the opposite side of the sinus cavity frame 12, there may be a slight gap between the free edge 202 and the membrane 3. At this time, the free edge 202 does not fit the membrane 3, so that the The risk of adhesion between the free edge 202 and the stent body 11 or the membrane 3 is reduced, and the small gap between the free edge 202 and the membrane 3 does not affect the valve 2 to block most of the backflow blood flow.
  • the valve 2 may include a valve body 21 and a valve leaflet 22 .
  • the valve body 21 constitutes the above-mentioned fixed edge 201 and is connected and fixed with the venous valve stent 1.
  • the valve leaflet 22 is connected between the valve bodies 21. When the valve leaflet 22 is expanded into a plane, the area is greater than the area enclosed by the fixed edge 201.
  • the part of the edge 22 that is not combined with the valve body 21 constitutes a free edge 202 .
  • the middle part of the valve leaflet 22 is beyond the plane where the valve body 21 is located, and a sinus cavity is formed between the valve leaflet 22 and the valve body 21 .
  • the valve leaflet 22 can be deformed, and through the deformation of the valve leaflet 22, the position of the free edge 202 of the valve leaflet 22 can be changed, so as to realize the switching of the closed state and the open state.
  • a one-way passage of blood when passing through the venous valve stent 1 can be constructed, and the valve 2 is used as a one-way valve.
  • Both the valve 2 and the membrane 3 are made of different biological materials or medical polymer materials, such as polyester, polytetrafluoroethylene, polyurethane, medical silicone, polyester, biological valve, pericardium or other implantable medical materials.
  • the venous valve stent 1 is attached to the intima of the blood vessel 500 .
  • blood flows from the distal end of the venous valve prosthesis 100 to the proximal end and into the heart.
  • the valve 2 moves toward the opposite side of the sinus cavity frame 12 under the impact of the blood flow under the action of the backflow blood flow from the proximal end to the distal end, thereby closing the channel in the stent body 11 101, effectively avoiding the backflow of blood at the distal end.
  • the eddy current formed in the sinus region 102 makes the backflow blood flow to the proximal end again, so as to avoid blood retention and accumulation at the root of the valve 2, thereby avoiding the formation of local thrombus.
  • the area of the sinus region 102 covered by the valve 2 forms a vortex, which is beneficial to the pressure balance of the valve 2.
  • the valve leaflet 22 of the valve 2 is in the Under the combined action of eddy current and downstream blood flow, it is in a suspended state, and does not adhere to the stent body 11, the membrane 3 or the inner wall of the blood vessel 500, thereby reducing the risk of adhesion, so as to ensure that the valve 2 continues to have a one-way closing function,
  • the formed vortex can also avoid the risk of thrombosis due to blood flow retention at the root of the valve 2 .
  • the sinus region 102 is formed on the venous valve stent 1
  • the existence of the sinus region 102 enables the backflowing blood to form a vortex in the sinus region 102.
  • the pressure balance generated by the eddy current in the sinus region 102 enables the valve 2 to open the channel 101 while the leaflets 22 of the valve 2 are suspended in the channel 101 without sticking to the venous valve stent 1 or membrane 3 This reduces the risk of failure of the valve leaflets 22 due to adhesion.
  • the valve 2 can more easily close the channel 101 by the blood flow impinging on the suspended valve leaflet 22 than by impinging on the venous valve stent 1 or the membrane 3 .
  • the stent body 11 of the venous valve stent 1 is a radially expandable structure, and has a small size before being implanted into the blood vessel 500, and the surgical trauma is small.
  • the stent body 11 adopts the support body 111 with a closed-loop structure at both ends, which has the advantages of high radial support force and strong anchoring force. Uniform force is applied to the intima of the blood vessel 500 , thereby reducing stimulation to the intima of the blood vessel 500 , and preventing excessive proliferation of the intima of the blood vessel 500 .
  • the upright column 112 located in the middle of the stent body 11 increases the axial stiffness of the venous valve stent 1, so that the stent body 11 part of the load valve 2 does not change in diameter due to factors such as muscle pump and pressure gradient changes.
  • the entire structure of the venous valve stent 1 exhibits greater rigidity, and the venous valve stent 1 always maintains a fixed shape after implantation, and does not affect the valve body 21 of the valve 2 and thus the function of the valve leaflets 22 due to changes in the transmural pressure of the blood vessel 500 .
  • the sinus cavity frame 12 of the venous valve stent 1 forms a sinus region 102 on the side of the stent body 11 , forming a structural advantage in line with hydrodynamics, so that blood does not generate thrombus at the valve 2 .
  • the sinus cavity frame 12 adopts a design with a suspended free end 1203 to have elasticity in the radial direction, which can avoid excessive stimulation of the blood vessel 500 by the sinus cavity frame 12 .
  • the support body 111 closer to the proximal end of the sinus cavity frame 12 will not constrain the free end 1203, and the sinus cavity frame 12 can be more easily maintained at least partially outside. Convex the structural form of the stent body 11 , thereby maintaining the stability of the sinus region 102 .
  • the sinus cavity frame 12 of this embodiment is formed by connecting the first support rod 121 and the second support rod 122 to the support body 11 , with few structural parts and a simple structure.
  • the stent body 11 and the sinus cavity frame 12 can be manufactured separately first, and then the two are connected as a whole, which is convenient for manufacture.
  • the sinus cavity frame 12 is connected with the upright post 112, and the sinus cavity frame 12 with a simple structure is matched with the upright posts 112 arranged at intervals, so that the venous valve stent 1 also has a large operating space for the connection of the valve 2, and the metal coverage rate is small, which effectively reduces the Stimulation of blood vessel 500 intima.
  • the sinus cavity frame 12 is not limited to adopt the structural form composed of the first strut 121 and the second strut 122 in this embodiment. Based on the concept of the present invention, the sinus cavity frame 12 only needs to meet the following conditions: one end is a fixed end that is fixedly connected to the bracket body 11 , the opposite end is a free end 1203 that is suspended in the air, and the sinus cavity frame 12 is at least partially in the bracket body. The radial direction of 11 protrudes outward from the stent body 11 to form a sinus region 102 on the inner side of the sinus cavity frame 12 .
  • the portions where the proximal end portion of the first support rod 121 and the proximal end portion of the second support rod 122 are respectively connected to the bracket body 11 constitute fixed ends.
  • the overall structural shape of the sinus cavity frame 12 is not constrained by the stent body 11 or specifically the fenestration 115 of the stent body 11 .
  • the structural form of the sinus cavity frame 12 is flexibly set, which facilitates the manufacture of the sinus cavity frame 12 and the connection with the stent body 11 .
  • the venous valve stent 1 in this embodiment can be manufactured by laser engraving of NiTi alloy.
  • the total length L1 of the venous valve stent 1 (excluding the length of the developing rod 1112 ) may be 15 mm ⁇ 30 mm
  • the diameter D1 of the support body 111 may be 5 mm ⁇ 30 mm
  • the maximum diameter D2 where the sinus cavity frame 12 is located is smaller than The diameter D1 of the support body 111 protrudes by 2.5 mm.
  • the thickness of the venous valve stent 1 can be designed to be 0.35mm, the width of each rod in the support body 111 can be designed to be 0.35mm, and the width of each rod in the upright post 112 and the sinus cavity frame 12 can be designed to be 0.6mm, so that the venous valve stent 1 has Better radial support and axial stiffness.
  • the difference between the venous valve prosthesis 100a of this embodiment and the first embodiment is that the venous valve stent 1a of the venous valve prosthesis 100a has a plurality of sinus regions 102a, and in this embodiment, there are two sinus regions 102a .
  • the valve 2a has a double valve structure.
  • the membrane 3a covers the two sinus regions 102a.
  • the venous valve stent 1a has two sinus cavity frames 12a disposed opposite to each other, and the two sinus cavity frames 12a respectively protrude outward relative to the stent body 11a, so that the directions of the two sinus regions 102a are also opposite.
  • the two valves 2a are sewn between the two sinus frames 12a.
  • the free edges 202a of the two valves 2a meet in the middle of the venous valve stent 1a.
  • the two valves 2a When blood flows back, the two valves 2a are arched, and the free edges 202a of the two valves 2a are abutted together to close the channel 101a and prevent the backflow blood from passing through. Eddy currents are formed in the two sinus regions 102a, respectively, so as to promote blood to return to the proximal end and avoid blood accumulation.
  • the blood flow impacts the valve 2a, the free edges 202a of the two valves 2a are separated, and the channel 101a is opened to allow the blood to flow to the proximal end normally.
  • the structure of two sinus cavity stents 12a is adopted to effectively balance the open state of the valve 2a, and eddy currents are formed on both sides of the venous valve stent 1a to avoid local thrombosis caused by blood accumulation.
  • an additional upright 112a is provided in the interval between the two uprights 112a that are not connected to the sinus cavity frame 12a, that is, the stent body of this embodiment 11a has a total of six uprights 112a, increasing the radial support strength.
  • the extra two uprights 112a can also be omitted.
  • the second embodiment is described by taking a double valve as an example. Based on the concept of the present invention, the venous valve prosthesis can also have three or more sinus regions. Correspondingly, there are three-lobed and multi-lobed structures.
  • the venous valve stent 1b is provided with four sinus cavity frames 12b, and the four sinus cavity frames 12b are along the circumferential direction of the venous valve stent 1b Evenly distributed, they are respectively arranged between two adjacent uprights 112a. Accordingly, four sinus regions 102b are formed in the venous valve stent 1b.
  • the number of valves 2b is also corresponding to four, which are arranged one by one relative to the sinus region 102b.
  • the venous valve prosthesis 100c of this embodiment is different from the first embodiment in that the structure of the sinus cavity frame 12c of the venous valve stent 1c is different.
  • the free end 1203c of the sinus cavity frame 12c is not bent toward the inner side of the stent body 11c, instead, the sinus cavity frame 12c is divided into a first extension section 1201c near the distal end and a first extension section 1201c near the distal end along the axial direction of the stent body 11c.
  • the distance from the first extension section 1201c to the central axis L of the stent body 11c gradually increases, and the distance from the second extension section 1202c to the central axis L remains constant.
  • the projection of the second extension 1202c on the plane is parallel to the central axis L.
  • the free end 1203c of the sinus cavity frame 12c still does not extend beyond the outermost portion 1204c of the remaining part of the sinus cavity frame 12c except for the free end 1203c in the radial direction of the stent body 11c.
  • the distance from the second extension section 1202c to the central axis L remains unchanged.
  • the second extension section 1202c can avoid local stress concentration on the blood vessel wall and relieve the convexity of the sinus cavity frame 12c The pressure on the blood vessel wall to avoid excessive pressure on the blood vessel wall due to local stress concentration.
  • the difference between the venous valve prosthesis 100d of the present embodiment and the first embodiment is that the structure of the sinus cavity frame 12d of the venous valve stent 1d is different.
  • the sinus cavity frame 12d further includes a cross bar 123d.
  • the first support bar 121d and the second support 122d are connected by the cross bar 123d.
  • the cross bar 123d extends along the circumferential direction of the support body 11d.
  • the proximal end portion of the first strut 121d and the proximal end portion of the second strut 122d are respectively connected.
  • the arrangement of the cross bar 123d can increase the supporting area of the membrane 3d, and ensure the firm performance of the part of the membrane 3d covering the sinus area under the impact of eddy currents.
  • the transverse rod 123d can weaken the sharpness of the free end of the sinus cavity frame 12d, and the increase of the transverse area thereof can avoid damage to the vessel wall during implantation.
  • the venous valve prosthesis 100e of this embodiment is different from the first embodiment in that the connection position of the sinus cavity frame 12e and the stent body 11e in the venous valve stent 1e is different.
  • first strut 121e and the second strut 122e of the sinus cavity frame 12e are not connected to the ends of the upright post 112e, but are connected to the middle area of the upright post 112e.
  • the support body 111e has a distance S2, and in this embodiment, S1 and S2 are equal.
  • the venous valve prosthesis 100f of this embodiment is different from the first embodiment in that the structure of the stent body 11f of the venous valve stent 1f is different.
  • the support body 11f is an integrated mesh support, and the entire outer peripheral wall thereof is mesh-shaped, and no longer has the upright column 112 as in the first embodiment.
  • a substantially rectangular notch is formed on the side of the bracket body 11f to form a window 115f, and the window 115f is located in the middle area of the bracket body 11f in the axial direction of the bracket body 11f.
  • the sinus cavity frame 12f is provided at the opening 115f.
  • the support body 11f includes a plurality of annular wave rings 1111f, and the plurality of annular wave rings 1111f are arranged in sequence along the axis of the support body 11f and axially connect to form a grid. And the opening 115f may be formed by cutting on the bracket body 11f.
  • This embodiment adopts the stent body 11f of an integrated mesh structure, which has better radial contraction and expansion performance.
  • the window 115f provided on the side of the stent body 11f can improve the overall compliance performance of the venous valve stent 1f.
  • the venous valve stent 1f can be bent at the fenestration 115f, so that it can pass through the circuitous and complicated vascular access more easily, and has higher flexibility than the first embodiment.

Abstract

A venous valve stent (1), which comprises a stent body (11) and at least one sinus cavity frame (12); the stent body (11) is a hollow cylindrical structure and can radially extend and retract; a window (115) is arranged on a side part of the stent body (11); each sinus cavity frame (12) has a fixed end and an opposing free end (1203); the fixed end is connected to an edge of a corresponding window (115); the free end (1203) is arranged in suspension; at least a portion of the sinus cavity frame (12) protrudes out from the stent body (11) in the radial direction of the stent body (11); a sinus area (102) is formed by an inner side of the sinus cavity frame (12), and the sinus area (102) is in communication with an inner part of the stent body (11) via the window (115). A venous valve prosthesis (100), which comprises a valve (2) and the venous valve stent (1), the valve (2) is fixed within the stent body (11), the valve (2) and at least a portion of the sinus cavity frame (12) are opposing in the radial direction of the stent body (11), and a side of the valve (2) away from the sinus cavity frame (12) is a free edge (202). This kind of structure can improve the reliability of a one-way guiding function, is able to prevent excessive stimulation of a blood vessel, and is also convenient to make.

Description

静脉瓣支架及静脉瓣假体Venous valve stent and venous valve prosthesis 技术领域technical field
本发明涉及医疗器械技术领域,特别涉及一种静脉瓣支架及静脉瓣假体。The invention relates to the technical field of medical devices, in particular to a venous valve stent and a venous valve prosthesis.
背景技术Background technique
静脉外科疾病是外科常见病,多发生于下肢,其主要临床表现为静脉曲张、肢体肿胀、足靴区皮肤营养障碍性病变,如皮炎,色素沉着和溃烂形成等。其主要病理原因是,在致病因素作用下静脉瓣膜失去单向开放的基本功能。静脉疾病轻者妨碍生活和工作能力,重者可致程度不同的病残。因此,下肢静脉瓣膜疾病的治疗日益受到重视。目前,临床上对该疾病大部分仍采用保守治疗,如药物治疗、压力泵等,外科手术治疗如股静脉瓣膜修复重建术等,临床效果并不理想。特别是当静脉瓣膜严重破坏或先天性无瓣症的患者,静脉瓣膜移植似乎是唯一可选择的方法。Venous surgery disease is a common disease in surgery, which mostly occurs in the lower extremities. Its main clinical manifestations are varicose veins, limb swelling, and skin dystrophic lesions in the boot area, such as dermatitis, pigmentation, and ulceration. The main pathological reason is that the venous valve loses the basic function of one-way opening under the action of pathogenic factors. Mild cases of venous disease hinder the ability to live and work, and severe cases can cause different degrees of disability. Therefore, the treatment of lower extremity venous valve disease has received increasing attention. At present, most of the clinical treatment of the disease is still conservative, such as drug therapy, pressure pump, etc., and surgical treatment such as femoral vein valve repair and reconstruction, etc., the clinical effect is not ideal. Especially in patients with severely damaged venous valves or congenital avalvular disease, venous valve transplantation seems to be the only option.
目前临床常采用的是自体带瓣膜的髂静脉假体或腘静脉假体移植,假体植入静脉血管中,假体的支架与血管贴合,在支架内部构建血液通过的通道,位于支架内部的瓣膜可以开放或关闭通道实现单向开放功能。但这样的结构中,瓣膜与支架之间容易形成局部血栓,另外瓣膜也容易出现退变以及抗返流能力不够的问题,远期来看,效果并不理想。At present, the autologous valved iliac vein prosthesis or popliteal vein prosthesis is often used in clinic. The prosthesis is implanted into the venous blood vessel, and the stent of the prosthesis is attached to the blood vessel. The valve can open or close the channel to achieve a one-way opening function. However, in such a structure, local thrombus is easily formed between the valve and the stent, and the valve is also prone to degeneration and insufficient anti-reflux capability. In the long run, the effect is not ideal.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种可靠性更好的静脉瓣支架及静脉瓣假体。The purpose of the present invention is to provide a venous valve stent and a venous valve prosthesis with better reliability.
为解决上述技术问题,本发明采用如下技术方案:In order to solve the above-mentioned technical problems, the present invention adopts the following technical solutions:
根据本发明的一个方面,本发明提供一种静脉瓣支架,包括支架本体及至少一个窦腔架;支架本体呈中空的筒状结构且可径向伸缩;该支架本体的侧部设有至少一个开窗;至少一个窦腔架对应于所述至少一个开窗设置;每一窦腔架具有相对的固定端和自由端;所述固定端连接于对应的一所述开窗的边缘;所述自由端悬空设置;所述窦腔架的至少部分在所述支架本体的径向上向外凸出于所述支架本体;所述窦腔架的内侧形成窦区,所述窦区经所述开窗与所述支架本体内部相通。According to one aspect of the present invention, the present invention provides a venous valve stent, comprising a stent body and at least one sinus cavity frame; the stent body has a hollow cylindrical structure and can be radially expanded and contracted; the side portion of the stent body is provided with at least one fenestration; at least one sinus cavity frame is arranged corresponding to the at least one fenestration; each sinus cavity frame has opposite fixed ends and free ends; the fixed end is connected to a corresponding edge of the fenestration; the The free end is suspended; at least part of the sinus cavity frame protrudes outward from the stent body in the radial direction of the stent body; the inner side of the sinus cavity frame forms a sinus area, and the sinus area passes through the opening. The window communicates with the inside of the bracket body.
在一些实施例中,在沿所述支架本体径向上,所述自由端不超出所述窦腔架除所述自由端以外剩余部分的最外侧部位。In some embodiments, along the radial direction of the stent body, the free end does not extend beyond the outermost portion of the rest of the sinus cage except the free end.
在一些实施例中,所述窦腔架包括第一延伸段和第二延伸段,所述第二延伸段通过所述第一延伸段连接所述支架本体,所述第一延伸段与所述第二延伸段连接的部位形成所述窦腔架的最外侧部位,所述第二延伸段的末端形成所述自由端,所述第一延伸段与所述支架本体连接的部位形成所述固定端,所述最外侧部位与所述支架本体的中心轴之间的距离大于所述固定端与所述支架本体的中心轴之间的距离。In some embodiments, the sinus lumen frame includes a first extension section and a second extension section, the second extension section is connected to the stent body through the first extension section, and the first extension section is connected to the stent body. The part where the second extension is connected forms the outermost part of the sinus cavity frame, the end of the second extension forms the free end, and the part where the first extension is connected with the stent body forms the fixing The distance between the outermost part and the central axis of the bracket body is greater than the distance between the fixed end and the central axis of the bracket body.
在一些实施例中,所述自由端与所述支架本体的中心轴之间的距离小于所述最外侧部位与所述支架本体的中心轴之间的距离。In some embodiments, the distance between the free end and the central axis of the stent body is smaller than the distance between the outermost portion and the central axis of the stent body.
在一些实施例中,所述第二延伸段呈曲线弯曲延伸,且曲线往背离所述支架本体的方向凸出。In some embodiments, the second extension section extends in a curved line, and the curved line protrudes in a direction away from the bracket body.
在一些实施例中,所述第二延伸段呈直线状延伸。In some embodiments, the second extension segment extends linearly.
在一些实施例中,在穿过所述中心轴和所述自由端的平面上看,所述第二延伸段在该平面上的投影与所述中心轴平行。In some embodiments, viewed on a plane passing through the central axis and the free end, the projection of the second extension on the plane is parallel to the central axis.
在一些实施例中,所述第一延伸段呈曲线弯曲延伸,且曲线往背离所述支架本体的方向凸出。In some embodiments, the first extension section extends in a curved shape, and the curved line protrudes in a direction away from the bracket body.
在一些实施例中,所述第一延伸段呈直线状延伸。In some embodiments, the first extension segment extends linearly.
在一些实施例中,所述窦腔架包括第一支杆和连接所述第一支杆的第二支杆,所述第一支杆和所述第二支杆分别连接所述支架本体,所述第一支杆和所述第二支杆分别连接所述支架本体的部位形成所述固定端;所述第一支杆和所述第二支杆连接的部位形成所述自由端。In some embodiments, the sinus cavity rack includes a first strut and a second strut connected to the first strut, the first strut and the second strut are respectively connected to the stent body, The fixed end is formed at the part where the first support rod and the second support rod are connected to the bracket body respectively; the free end is formed at the connection part of the first support rod and the second support rod.
在一些实施例中,所述第一支杆和所述第二支杆直接连接。In some embodiments, the first strut and the second strut are directly connected.
在一些实施例中,所述窦腔架还包括横杆,所述第一支杆和所述第二支杆通过所述横杆连接。In some embodiments, the sinus cage further includes a cross bar through which the first strut and the second strut are connected.
在一些实施例中,在沿所述第一端至所述第二端的方向上,所述第一支杆和所述支架本体连接的部位与所述第二支杆和所述支架本体连接的部位之间的距离,大于所述第一支杆和所述横杆连接的部位与所述第二支杆和所述横杆连接的部位之间的距离。In some embodiments, in the direction from the first end to the second end, the part where the first strut and the bracket body are connected is connected to the second strut and the bracket body. The distance between the parts is greater than the distance between the part where the first support rod and the cross rod are connected and the part where the second support rod and the cross rod are connected.
在一些实施例中,所述第一支杆和所述第二支杆之间的夹角为30°~90°。In some embodiments, the included angle between the first strut and the second strut is 30°˜90°.
在一些实施例中,所述第一支杆和所述第二支杆对称。In some embodiments, the first strut and the second strut are symmetrical.
在一些实施例中,至少一个所述开窗位于所述支架本体轴向的中部区域。In some embodiments, at least one of the fenestrations is located in an axially central region of the stent body.
在一些实施例中,所述窦腔架在沿所述支架本体轴向上的长度大于对应的所述开窗在沿所述支架本体轴向上的长度的一半。In some embodiments, the length of the sinus cage in the axial direction of the stent body is greater than half the length of the corresponding fenestration in the axial direction of the stent body.
在一些实施例中,所述支架本体包括至少两个支撑体和多个立柱,每个所述立柱连接间隔的两个所述支撑体,所述开窗由所述支撑体和所述立柱合围成。In some embodiments, the bracket body includes at least two supporting bodies and a plurality of uprights, each of the uprights is connected to two of the supporting bodies at intervals, and the window is enclosed by the supporting bodies and the uprights become.
在一些实施例中,每个所述支撑体包括轴向相接的多个波形圈;每个波形圈沿周向具有相交错的波峰和波谷,在相邻两个波形圈中,其中一个所述波形圈的波峰与另一个所述波形圈的波谷连接形成网格状。In some embodiments, each of the supporting bodies includes a plurality of wave circles that are connected in the axial direction; each wave circle has staggered wave crests and wave troughs along the circumferential direction, and in two adjacent wave circles, one of the wave circles is The peaks of the wave circles are connected with the valleys of the other wave circles to form a grid.
在一些实施例中,其中一个所述支撑体的波峰通过所述立柱连接另一个所述支撑体的波谷。In some embodiments, the peaks of one of the supports are connected to the troughs of the other support through the posts.
在一些实施例中,所述立柱呈直线状,且沿所述支架本体的轴向延伸。In some embodiments, the uprights are linear and extend along the axial direction of the stent body.
在一些实施例中,所述支架本体为一体结构,其整个外周壁均呈网状,所述外周壁上开设至少一个所述开窗。In some embodiments, the bracket body is an integral structure, the entire outer peripheral wall thereof is in the shape of a mesh, and at least one of the openings is defined on the outer peripheral wall.
在一些实施例中,所述开窗的数量为多个,多个所述开窗沿所述支架本体周向分布;所述窦腔架设有多个,一一对应连接于所述开窗的边缘。In some embodiments, the number of the fenestrations is multiple, and the multiple fenestrations are distributed along the circumference of the stent body; the sinus cavity frame is provided with a plurality of fenestrations, which are connected to the fenestrations in one-to-one correspondence. edge.
根据本发明的另一个方面,本发明提供一种静脉瓣假体,包括瓣膜以及如上所述的静脉瓣支架;所述瓣膜固定于所述支架本体内,所述瓣膜与所述窦腔架的至少部分在所述支 架本体的径向上相对;所述瓣膜具有自由边缘,所述自由边缘位于所述瓣膜背离所述窦区的一侧。According to another aspect of the present invention, the present invention provides a venous valve prosthesis, comprising a valve and the above-mentioned venous valve stent; the valve is fixed in the stent body, and the valve is connected to the sinus cavity frame. At least partially opposite in the radial direction of the stent body; the valve has a free edge on the side of the valve facing away from the sinus region.
在一些实施例中,所述静脉瓣假体还包括薄膜,所述薄膜覆盖所述静脉瓣支架的整个周壁。In some embodiments, the venous valve prosthesis further comprises a membrane covering the entire peripheral wall of the venous valve stent.
由上述技术方案可知,本发明至少具有如下优点和积极效果:本发明的静脉瓣支架中,支架本体为可径向伸缩的筒状结构,因此静脉瓣支架在植入人体前可以呈收缩状态地容置在输送导管中,从而利用输送导管将其输送到静脉内,手术创口小。在植入人体后,支架本体通过自膨胀而径向张开锚定在血管内,支架本体内得以构建供血液通过的通道,并能够配合负载于该静脉瓣支架内的瓣膜,重建静脉的单向导通功能,并防止静脉血液返流。As can be seen from the above technical solutions, the present invention has at least the following advantages and positive effects: in the venous valve stent of the present invention, the stent body is a radially retractable cylindrical structure, so the venous valve stent can be in a contracted state before being implanted in the human body. It is accommodated in the delivery catheter, so that it can be delivered into the vein using the delivery catheter, and the surgical incision is small. After being implanted into the human body, the stent body is radially expanded and anchored in the blood vessel through self-expansion. The stent body can build a channel for blood to pass through, and can cooperate with the valve loaded in the venous valve stent to reconstruct the single venous valve. To guide function, and prevent venous blood reflux.
特别地,该静脉瓣支架具有相对于支架本体外凸的窦腔架,在窦腔架内侧形成窦区。该静脉瓣支架负载瓣膜,可以在血液返流时在窦区形成涡流。基于该窦区中形成的涡流,在血液顺流时,顺流血液对瓣膜的作用力与涡流产生的压力相平衡,能够使得瓣膜的瓣叶悬浮而不与静脉瓣支架接触,减少瓣叶粘合的风险;并且在血液返流时,返流血液冲击悬浮的瓣叶相比冲击贴合静脉瓣支架的瓣叶而言,能够更容易地使瓣叶向关闭血流通道的方向变形而快速关闭通道,提高单向开放功能的灵敏性和可靠性。同时,在窦区内涡流的作用下,可以引导返流血液重新向心脏方向流动,有效避免血液的聚积,降低形成局部血栓的风险。In particular, the venous valve stent has a sinus cavity frame that protrudes outward relative to the stent body, and a sinus area is formed inside the sinus cavity frame. The venous valve stent is loaded with a valve that can create eddy currents in the sinus region when blood flows back. Based on the vortex formed in the sinus area, when the blood flows downstream, the force of the downstream blood on the valve is balanced with the pressure generated by the vortex, so that the valve leaflet of the valve can be suspended without contacting the venous valve stent, reducing the stickiness of the valve leaflet. In addition, when the blood flows back, the backflowing blood impinges on the valve leaflets in suspension, which can more easily deform the valve leaflets in the direction of closing the blood flow channel, and quickly causes the valve leaflets to be deformed in the direction of closing the blood flow channel rather than impacting the valve leaflets that fit the venous valve stent. Close the channel to improve the sensitivity and reliability of the one-way open function. At the same time, under the action of the eddy current in the sinus area, the regurgitated blood can be guided to flow toward the heart again, which can effectively avoid the accumulation of blood and reduce the risk of local thrombosis.
进一步地,本方案中,窦腔架的自由端悬空设置,使得窦腔架在径向上具有弹性,可以避免窦腔架对血管的过度刺激,减轻对血管的损伤,防止血管内膜过度增生。同时,窦腔架通过其固定端连接于支架本体的开窗的边缘,窦腔架的结构形状不受支架本体的约束,便于窦腔架的制作以及与支架本体的连接,并且在植入人体后,也便于保持窦腔架外凸于支架本体的结构形式从而维持窦区的稳定性。Further, in this solution, the free end of the sinus cavity frame is suspended, so that the sinus cavity frame is elastic in the radial direction, which can avoid excessive stimulation of the blood vessel by the sinus cavity frame, reduce damage to the blood vessel, and prevent excessive intimal hyperplasia of the blood vessel. At the same time, the sinus cavity frame is connected to the fenestration edge of the stent body through its fixed end, and the structure and shape of the sinus cavity frame is not constrained by the stent body, which is convenient for the manufacture of the sinus cavity frame and the connection with the stent body. Afterwards, it is also convenient to maintain the structural form of the sinus cavity frame protruding from the stent body so as to maintain the stability of the sinus area.
附图说明Description of drawings
图1是本发明静脉瓣假体第一实施例的结构示意图。FIG. 1 is a schematic structural diagram of the first embodiment of the venous valve prosthesis of the present invention.
图2是图1的主视图。FIG. 2 is a front view of FIG. 1 .
图3是图1的俯视图。FIG. 3 is a plan view of FIG. 1 .
图4是图1去除薄膜后的结构示意图。FIG. 4 is a schematic view of the structure of FIG. 1 after removing the thin film.
图5是图1中静脉瓣支架的主视图。FIG. 5 is a front view of the venous valve stent of FIG. 1 .
图6是图5的侧视图。FIG. 6 is a side view of FIG. 5 .
图7和图8是图1在植入人体血管后的剖面示意图,图中分别示意了瓣膜打开和封闭的状态。FIG. 7 and FIG. 8 are schematic cross-sectional views of FIG. 1 after implantation in a human blood vessel, and the figures illustrate the open and closed states of the valve, respectively.
图9是本发明静脉瓣假体第二实施例的结构示意图。FIG. 9 is a schematic structural diagram of the second embodiment of the venous valve prosthesis of the present invention.
图10是图9的俯视图。FIG. 10 is a plan view of FIG. 9 .
图11是图9的内部结构示意图。FIG. 11 is a schematic diagram of the internal structure of FIG. 9 .
图12是图9中静脉瓣支架的结构示意图。FIG. 12 is a schematic structural diagram of the venous valve stent in FIG. 9 .
图13是本发明静脉瓣假体第三实施例的结构示意图。Fig. 13 is a schematic structural diagram of the third embodiment of the venous valve prosthesis of the present invention.
图14是图13的俯视图。FIG. 14 is a plan view of FIG. 13 .
图15是本发明静脉瓣假体第四实施例的结构示意图。Fig. 15 is a schematic structural diagram of the fourth embodiment of the venous valve prosthesis of the present invention.
图16是图15中静脉瓣支架的结构示意图。FIG. 16 is a schematic structural diagram of the venous valve stent in FIG. 15 .
图17是本发明静脉瓣假体第五实施例的结构示意图。17 is a schematic structural diagram of the fifth embodiment of the venous valve prosthesis of the present invention.
图18是图17的主视图。FIG. 18 is a front view of FIG. 17 .
图19是本发明静脉瓣假体第六实施例的结构示意图。Fig. 19 is a schematic structural diagram of the sixth embodiment of the venous valve prosthesis of the present invention.
图20是图19中静脉瓣支架的侧视图。FIG. 20 is a side view of the venous valve stent of FIG. 19 .
图21是图20的主视图。FIG. 21 is a front view of FIG. 20 .
图22是本发明静脉瓣假体第七实施例的结构示意图。Fig. 22 is a schematic structural diagram of the seventh embodiment of the venous valve prosthesis of the present invention.
图23是图22的主视图。FIG. 23 is a front view of FIG. 22 .
附图标记说明如下:The reference numerals are explained as follows:
100/100a/100b/100c/100d/100e/100f、静脉瓣假体;500、血管;100/100a/100b/100c/100d/100e/100f, venous valve prosthesis; 500, blood vessel;
1/1a/1b/1c/1d/1e/1f、静脉瓣支架;101/101a、通道;102/102a/102b、窦区;1/1a/1b/1c/1d/1e/1f, venous valve stent; 101/101a, channel; 102/102a/102b, sinus area;
11/11a/11c/11d/11e/11f、支架本体;111/111e、支撑体;1111/1111f、波形圈;1115、波峰;1116、波谷;1112、显影杆;112/112a/112b/112e、立柱;115/115f、开窗;11/11a/11c/11d/11e/11f, stent body; 111/111e, support body; 1111/1111f, wave circle; 1115, crest; 1116, trough; 1112, developing rod; 112/112a/112b/112e, Column; 115/115f, window opening;
12/12a/12b/12c/12d/12e/12f、窦腔架;1201/1201c、第一延伸段;1202/1202c、第二延伸段;1203/1203c、自由端;1204/1204c、最外侧部位;121/121d/121e、第一支杆;122/122d/122e、第二支杆;123d、横杆;12/12a/12b/12c/12d/12e/12f, sinus frame; 1201/1201c, first extension; 1202/1202c, second extension; 1203/1203c, free end; 1204/1204c, outermost part ; 121/121d/121e, first pole; 122/122d/122e, second pole; 123d, cross pole;
2/2a/2b、瓣膜;201、固定边缘;202/202a、自由边缘;21、瓣体;22、瓣叶;2/2a/2b, valve; 201, fixed edge; 202/202a, free edge; 21, valve body; 22, leaflet;
3/3a/3d、薄膜。3/3a/3d, film.
具体实施方式Detailed ways
体现本发明特征与优点的典型实施方式将在以下的说明中详细叙述。应理解的是本发明能够在不同的实施方式上具有各种的变化,其皆不脱离本发明的范围,且其中的说明及图示在本质上是当作说明之用,而非用以限制本发明。Exemplary embodiments embodying the features and advantages of the present invention will be described in detail in the following description. It should be understood that the present invention can have various changes in different embodiments without departing from the scope of the present invention, and the descriptions and drawings therein are essentially used for illustration rather than limitation this invention.
本发明提供一种静脉瓣支架和静脉瓣假体,用于静脉瓣膜功能不全的介入治疗。该静脉瓣假体包括该静脉瓣支架和连接于该静脉瓣支架内的瓣膜。该静脉瓣假体利用经皮穿刺的方式通过输送导管将其输送到病变的静脉内并精准定位释放,以起到防止静脉血液返流的作用。The invention provides a venous valve stent and a venous valve prosthesis, which are used for the interventional treatment of venous valve insufficiency. The venous valve prosthesis includes the venous valve stent and a valve connected within the venous valve stent. The venous valve prosthesis is delivered into the diseased vein by means of percutaneous puncture through a delivery catheter, and is precisely positioned and released, so as to prevent venous blood backflow.
为便于表述,本文中定义“近端”是指靠近心脏位置的一端,“远端”是指远离心脏位置的一端。人体静脉中正常血液流向为向心脏方向流动,即从远端流向近端。For ease of presentation, it is defined herein that "proximal" refers to the end close to the location of the heart, and "distal" refers to the end that is remote from the location of the heart. The normal direction of blood flow in human veins is toward the heart, that is, from the distal end to the proximal end.
以下通过静脉瓣假体的几个实施例进行具体介绍。The following is a detailed introduction through several embodiments of the venous valve prosthesis.
第一实施例,参阅图1至图8所示的结构及使用状态。For the first embodiment, please refer to the structures and usage states shown in FIG. 1 to FIG. 8 .
首先参阅图1至图4,本实施例的静脉瓣假体100包括静脉瓣支架1、瓣膜2以及薄膜3。Referring first to FIGS. 1 to 4 , the venous valve prosthesis 100 of this embodiment includes a venous valve stent 1 , a valve 2 and a membrane 3 .
其中,静脉瓣支架1为裸支架,其在展开状态下内部形成贯通远端和近端的供血液通过的通道101,本实施例中静脉瓣支架1侧部还形成有外凸的窦区102。薄膜3可以缝合、粘接或热压合在静脉瓣支架1的内侧,也可以缝合、粘接或热压合在静脉瓣支架1的外侧,覆盖静脉瓣支架1的整个周壁,薄膜3和静脉瓣支架1结合为整体,增加静脉瓣假体100与人体血管的接触面积。瓣膜2为单瓣结构,位于静脉瓣支架1内部,与静脉瓣支架1连接固定,并覆盖窦区102的至少部分,起到单向导通的作用。Among them, the venous valve stent 1 is a bare stent, which forms a channel 101 for blood to pass through the distal end and the proximal end in the unfolded state. In this embodiment, the side of the venous valve stent 1 is also formed with a convex sinus region 102 . The film 3 can be sutured, bonded or thermocompressed on the inner side of the venous valve stent 1, or can be sutured, bonded or thermocompressed on the outside of the venous valve stent 1, covering the entire peripheral wall of the venous valve stent 1, the film 3 and the venous valve stent 1. The valve stent 1 is combined into a whole, so as to increase the contact area between the venous valve prosthesis 100 and the human blood vessel. The valve 2 is a single-valve structure, located inside the venous valve stent 1 , connected and fixed with the venous valve stent 1 , and covers at least part of the sinus region 102 to function as one-way conduction.
参阅图5和图6,静脉瓣支架1包括支架本体11和连接于支架本体11侧部的一个窦腔架12。支架本体11整体上呈中空的筒状结构,因此在其内部得以形成通道101。支架本体11的侧部设置有开窗115;窦腔架12连接于开窗115的边缘处,并相对于支架本体11在径向上外凸,从而在窦腔架12内侧形成该窦区102,窦区102经该开窗115与支架本体11内部的通道101相连通。Referring to FIGS. 5 and 6 , the venous valve stent 1 includes a stent body 11 and a sinus cavity frame 12 connected to the side of the stent body 11 . The bracket body 11 has a hollow cylindrical structure as a whole, so a channel 101 can be formed in its interior. A fenestration 115 is provided on the side of the stent body 11; the sinus cavity frame 12 is connected to the edge of the fenestration 115 and protrudes radially outward relative to the stent body 11, thereby forming the sinus region 102 inside the sinus cavity frame 12, The sinus region 102 communicates with the channel 101 inside the stent body 11 through the fenestration 115 .
本实施例的支架本体11主要包括间隔设置的两支撑体111以及连接在两支撑体111之间的多个立柱112。The bracket body 11 of this embodiment mainly includes two supporting bodies 111 arranged at intervals and a plurality of uprights 112 connected between the two supporting bodies 111 .
支撑体111为自膨胀式结构,呈周向闭环的筒状,其中心轴与整个支架本体11的中心轴在同一直线上,该中心轴在图6中标示为L。两支撑体111同轴设置,并沿轴向间隔相对。The support body 111 is a self-expanding structure, and is in the shape of a cylindrical closed-loop in the circumferential direction. The two support bodies 111 are arranged coaxially and are opposite to each other along the axial direction.
每一支撑体111具有轴向相接的多个波形圈1111。每个波形圈1111沿周向具有相交错的波峰1115和波谷1116。其中,波峰1115朝向近端,波谷1116朝向远端。相邻两个波形圈1111的波峰1115与波谷1116连接形成网格状。Each support body 111 has a plurality of wave rings 1111 axially connected to each other. Each wave circle 1111 has crests 1115 and troughs 1116 that are staggered in the circumferential direction. The crest 1115 is toward the proximal end, and the trough 1116 is toward the distal end. The crests 1115 and troughs 1116 of two adjacent wave circles 1111 are connected to form a grid.
各个波形圈1111的相邻波峰1115之间以及相邻波谷1116之间可以相互靠近或远离,使得支撑体111以至整个支架本体11可以沿径向伸缩。支架本体11在植入人体前呈收缩状态以容置在输送导管中,在植入人体后通过自膨胀而张开锚定在人体血管的预定位置。特别地,主要是利用支撑体111径向张开后与人体血管贴壁结合实现锚定。The adjacent wave crests 1115 and adjacent wave troughs 1116 of each wave ring 1111 can be close to or away from each other, so that the support body 111 and the entire stent body 11 can expand and contract in the radial direction. The stent body 11 is in a contracted state before being implanted into the human body to be accommodated in the delivery catheter, and after being implanted into the human body, it expands and anchors at a predetermined position of the human blood vessel through self-expansion. In particular, the anchoring is mainly achieved by combining the support body 111 with the human blood vessel after radial expansion.
具体如图5所示的结构,每一支撑体111具有两个波形圈1111。各个波形圈1111可视为由杆件呈Z形弯曲延伸为闭环结构。每个波形圈1111共有周向交错布置的八个波峰1115和八个波谷1116。近端的波形圈1111的波谷1116与远端的波形圈1111的波峰1115相连接,在沿支撑体111周向上形成八个依次相连的菱形状的网格。两个波形圈1111组成周向闭环结构,使静脉瓣支架1具有高径向支撑力和更好的锚定效果。Specifically, as shown in FIG. 5 , each support body 111 has two corrugated circles 1111 . Each wave ring 1111 can be regarded as a closed-loop structure extending in a Z-shape from a rod. Each wave circle 1111 has eight wave crests 1115 and eight wave troughs 1116 arranged in a circumferentially staggered manner. The wave troughs 1116 of the wave ring 1111 at the proximal end are connected with the wave crests 1115 of the wave ring 1111 at the far end, forming eight successively connected diamond-shaped grids along the circumferential direction of the support body 111 . The two wave rings 1111 form a circumferential closed-loop structure, so that the venous valve stent 1 has high radial support force and better anchoring effect.
位于近端的支撑体111上向近端突伸出两个显影杆1112,位于远端的支撑体111上向远端突伸出两个显影杆1112。每一支撑体111上的两个显影杆1112在圆周上相对,四个显影杆1112在圆周上相交错。显影杆1112上可以设置显影标记,方便在植入时显示静脉瓣支架1的位置。显影标记采用显影材料设于显影杆1112上,可以设置为呈点状、线状等。本实施例中,显影杆1112的端部呈环状,可以用于压制点状的显影标记。Two developing rods 1112 protrude from the support body 111 located at the proximal end toward the proximal end, and two developing rods 1112 protrude toward the distal end from the support body 111 located at the distal end. The two developing rods 1112 on each supporting body 111 are circumferentially opposite, and the four developing rods 1112 are staggered circumferentially. A developing mark can be set on the developing rod 1112 to facilitate displaying the position of the venous valve stent 1 during implantation. The developing mark is set on the developing rod 1112 by using developing material, and can be set in a dot shape, a line shape, or the like. In this embodiment, the end of the developing rod 1112 is annular, which can be used for pressing dot-shaped developing marks.
各立柱112呈直线状,沿支架本体11的轴向延伸。多个立柱112绕支撑体111的中心轴L周向间隔布置。该多个立柱112所围合形成的筒状结构与支撑体111同轴。Each of the uprights 112 is linear and extends along the axial direction of the bracket body 11 . The plurality of uprights 112 are circumferentially spaced around the central axis L of the support body 111 . The cylindrical structure formed by the plurality of uprights 112 is coaxial with the support body 111 .
立柱112的两端分别与两支撑体111相对的波峰1115和波谷1116连接。即:立柱112的近端端部与近端的支撑体111的波谷1116连接,立柱112的远端端部与远端的支撑体111的对应的波峰1115连接。Two ends of the upright column 112 are respectively connected with the wave crests 1115 and the wave troughs 1116 opposite to the two support bodies 111 . That is, the proximal end of the upright post 112 is connected to the trough 1116 of the proximal support body 111 , and the distal end of the upright post 112 is connected to the corresponding wave crest 1115 of the distal support body 111 .
具体在本实施例中,立柱112数量为四个,在两支撑体111之间周向均匀布置,沿周向每隔至少一个波峰1115或波谷1116即连接一个立柱112。其中的两个相邻的立柱112之间的间隔形成一个开窗115,而两支撑体111之间的距离或者说该立柱112的长度构成该开窗115的轴向长度。Specifically, in this embodiment, the number of the uprights 112 is four, which are evenly arranged in the circumferential direction between the two support bodies 111 , and one upright post 112 is connected every at least one wave crest 1115 or wave trough 1116 along the circumferential direction. The interval between two adjacent uprights 112 forms a window 115 , and the distance between the two supports 111 or the length of the uprights 112 constitutes the axial length of the window 115 .
该支架本体11的结构,利用位于两端的呈闭环结构的支撑体111可以提供良好的径向支撑力,具有锚定力强的优点,便于与人体血管贴合固定。而位于中间的立柱112增加了该静脉瓣支架1的轴向刚度,便于静脉瓣支架1保持形状的稳定性。较佳地,立柱112的宽度大于支撑体111的波形圈1111的杆件宽度。The structure of the stent body 11 can provide good radial support force by using the support bodies 111 located at both ends in a closed-loop structure, and has the advantage of strong anchoring force, which is convenient for fitting and fixing with human blood vessels. The upright post 112 in the middle increases the axial rigidity of the venous valve stent 1 , which facilitates the venous valve stent 1 to maintain the stability of the shape. Preferably, the width of the upright post 112 is greater than the width of the rod of the wave ring 1111 of the support body 111 .
仍然参阅图5和图6,窦腔架12对应连接在支架本体11的开窗115处。窦腔架12包括第一支杆121和第二支杆122。第一支杆121的第一端也即远端端部和第二支杆122的第一端即远端端部相分离,并各连接于限定出该开窗115的一立柱112上。第一支杆121的第二端即近端端部和第二支杆122的第二端即近端端部相接,并形成窦腔架12的自由端1203;该自由端1203悬伸于支架本体11的外侧。第一支杆121、第二支杆122以及它们所连接的两个立柱112之间所围合的空间即形成窦区102。Still referring to FIGS. 5 and 6 , the sinus cavity frame 12 is correspondingly connected to the opening 115 of the stent body 11 . The sinus frame 12 includes a first strut 121 and a second strut 122 . The first end, ie, the distal end, of the first support rod 121 is separated from the first end, ie, the distal end, of the second support rod 122 , and each is connected to a post 112 that defines the window 115 . The second end, ie, the proximal end, of the first strut 121 is connected to the second end, ie, the proximal end, of the second strut 122, and forms a free end 1203 of the sinus frame 12; the free end 1203 is overhanging from the The outer side of the bracket body 11 . The space enclosed between the first strut 121 , the second strut 122 and the two uprights 112 to which they are connected forms the sinus area 102 .
如图5所示,本实施例中,在从远端至近端的方向上,第一支杆121和第二支杆122逐渐靠近彼此。第一支杆121的近端端部和第二支杆122的近端端部直接连接,第一支杆121和第二支杆122连接构成V字形。其中较佳地,第一支杆121和第二支杆122对称。第一支杆121和第二支杆122所形成的夹角α范围较佳在30°~90°之间。本实施例中,第一支杆121和第二支杆122的远端端部分别连接于两立柱112的远端端部,从而可以借由支撑体111的径向支撑力,保持第一支杆121和第二支杆122的相对位置。As shown in FIG. 5 , in this embodiment, in the direction from the distal end to the proximal end, the first strut 121 and the second strut 122 gradually approach each other. The proximal end of the first support rod 121 and the proximal end of the second support rod 122 are directly connected, and the first support rod 121 and the second support rod 122 are connected to form a V-shape. Preferably, the first support rod 121 and the second support rod 122 are symmetrical. The included angle α formed by the first support rod 121 and the second support rod 122 preferably ranges from 30° to 90°. In this embodiment, the distal ends of the first support rod 121 and the second support rod 122 are respectively connected to the distal ends of the two uprights 112 , so that the first support rod can be held by the radial support force of the support body 111 . The relative position of the rod 121 and the second support rod 122 .
在沿支架本体11的轴向由远端至近端的方向上,窦腔架12起始于立柱112的远端端部处,再向近端延伸越过立柱112的中点,但与位于近端的支撑体111之间具有间隔。即该窦腔架12在沿支架本体11轴向上的长度大于开窗115的轴向长度的一半,便于引导血液的流动,同时还可以便于薄膜3的布设。In the direction from the distal end to the proximal end along the axial direction of the stent body 11, the sinus cavity frame 12 starts at the distal end of the post 112, and then extends proximally beyond the midpoint of the post 112, but is different from the one located at the proximal end. There is a space between the support bodies 111 . That is, the length of the sinus cavity frame 12 in the axial direction of the stent body 11 is greater than half of the axial length of the fenestration 115 , which is convenient for guiding the flow of blood and also facilitating the arrangement of the membrane 3 .
参阅图6,在沿支架本体11的轴向由远端至近端的方向上,该窦腔架12相对于该支架本体11先逐渐向外倾斜延伸,再逐渐向内倾斜延伸。也即,该窦腔架12的自由端1203朝向支架本体11内侧弯曲,由此,使得该窦腔架12的自由端1203在沿支架本体11径向上不超出窦腔架12的最外侧部位1204,可以有效避免在植入人体血管时窦腔架12的自由端1203损伤血管组织。Referring to FIG. 6 , in the direction from the distal end to the proximal end along the axial direction of the stent body 11 , the sinus cavity frame 12 relative to the stent body 11 gradually extends outwardly and then gradually inwardly. That is, the free end 1203 of the sinus cavity frame 12 is bent toward the inner side of the stent body 11 , so that the free end 1203 of the sinus cavity frame 12 does not exceed the outermost part 1204 of the sinus cavity frame 12 along the radial direction of the stent body 11 . , which can effectively prevent the free end 1203 of the sinus cavity frame 12 from damaging the vascular tissue when implanted into a human blood vessel.
为便于表述,在沿支架本体11的轴向上,将该窦腔架12划分为靠近远端的第一延伸段1201和靠近近端的第二延伸段1202。在由远端至近端的方向上,第一延伸段1201的各个位置到支架本体11的中心轴L的距离Di逐渐变大,第二延伸段1202的各个位置到 支架本体11的中心轴L的距离Dj逐渐减小。第一延伸段1201的远端端部与支架本体11相连,第一延伸段1201与第二延伸段1202连接的部位即构成窦腔架12相对于支架本体11的最外侧部位1204,第二延伸段1202的末端即为所述的自由端1203。窦腔架12整体上呈弧形弯曲,从而窦腔架12在第一延伸段1201和第二延伸段1202的交接处不会形成明显的弯折边或不形成弯折棱边,可以进一步防止在植入人体血管时窦腔架12损伤血管组织。For convenience of description, along the axial direction of the stent body 11 , the sinus cavity frame 12 is divided into a first extension section 1201 near the distal end and a second extension section 1202 near the proximal end. In the direction from the distal end to the proximal end, the distance Di from each position of the first extension section 1201 to the central axis L of the stent body 11 gradually increases, and the distance from each position of the second extension section 1202 to the central axis L of the stent body 11 Dj gradually decreases. The distal end of the first extension section 1201 is connected to the stent body 11, and the part where the first extension section 1201 and the second extension section 1202 are connected constitutes the outermost part 1204 of the sinus frame 12 relative to the stent body 11. The second extension The end of the segment 1202 is the free end 1203 . The sinus cavity frame 12 is curved in an arc shape as a whole, so that the sinus cavity frame 12 will not form an obvious bending edge or a bending edge at the junction of the first extension section 1201 and the second extension section 1202, which can further prevent When implanted into a human blood vessel, the sinus cavity scaffold 12 damages the blood vessel tissue.
从该静脉瓣支架1的外观上看,支架本体11的支撑体111的外径为D1,该窦腔架12的最外侧部位1204与支撑体111的对侧的侧壁之间的距离为D2,D2>D1。D2与D1的差值则为窦腔架12向外突出的最大距离。From the appearance of the venous valve stent 1, the outer diameter of the support body 111 of the stent body 11 is D1, and the distance between the outermost part 1204 of the sinus cavity frame 12 and the side wall on the opposite side of the support body 111 is D2 , D2>D1. The difference between D2 and D1 is the maximum distance that the sinus cavity frame 12 protrudes outward.
进一步地,本实施例中,在由远端至近端的方向上,第一延伸段1201到中心轴L的距离的增加速度逐渐减小,而第二延伸段1202到中心轴L的距离减小速度逐渐变大。Further, in the present embodiment, in the direction from the distal end to the proximal end, the increasing speed of the distance from the first extending section 1201 to the central axis L gradually decreases, while the distance between the second extending section 1202 and the central axis L decreases the speed. gradually become larger.
也就是说,第一支杆121和第二支杆122在第一延伸段1201的范围和第二延伸段1202的范围皆呈曲线弯曲,且第一延伸段1201和第二延伸段1202的曲线均是往背离支架本体11的方向凸出,可以提高第一支杆121和第二支杆122的抗变形能力。并且在植入人体血管时,第一支杆121和第二支杆122弯曲的方向均是向血管凸出,第一支杆121和第二支杆122可以承受更大的由血管壁带来的径向压力,便于保持形状的稳定。That is to say, the first support rod 121 and the second support rod 122 are both curved in the range of the first extension section 1201 and the range of the second extension section 1202 , and the curves of the first extension section 1201 and the second extension section 1202 are curved. Both are protruding in the direction away from the bracket body 11 , which can improve the deformation resistance of the first support rod 121 and the second support rod 122 . And when implanted into a human blood vessel, the bending directions of the first strut 121 and the second strut 122 are both protruding toward the blood vessel, and the first strut 121 and the second strut 122 can withstand greater damage caused by the blood vessel wall. The radial pressure is easy to maintain the stability of the shape.
可以理解的是,在其他可行的结构中,第一延伸段1201和第二延伸段1202还可以是均呈直线段延伸,在由远端至近端的方向上,第一延伸段1201到中心轴L的距离的增加速度保持不变,第二延伸段1202到中心轴L的距离减小速度也保持不变。也即,第一支杆121和第二支杆122在第一延伸段1201的范围和第二延伸段1202的范围均为直段结构。另外,在第一延伸段1201呈曲线状延伸时,第二延伸段1202可以是呈直线状延伸。在第一延伸段1201呈直线状延伸时,第二延伸段1202也可以是呈曲线状延伸。It can be understood that, in other feasible structures, the first extension section 1201 and the second extension section 1202 may also both extend in a straight line, and in the direction from the distal end to the proximal end, the first extension section 1201 reaches the central axis L The increasing speed of the distance remains unchanged, and the decreasing speed of the distance between the second extension section 1202 and the central axis L also remains unchanged. That is, the first support rod 121 and the second support rod 122 are both straight-section structures in the range of the first extension section 1201 and the range of the second extension section 1202 . In addition, when the first extension section 1201 extends in a curve shape, the second extension section 1202 may extend in a straight line. When the first extension section 1201 extends in a straight line, the second extension section 1202 may also extend in a curve shape.
本实施例的窦腔架12的结构形式简单,易于制作。且该窦腔架12的结构件数量少,金属覆盖率小,避免对人体血管的过度刺激引起内膜增生。利用窦腔架12内侧形成的窦区102,可以使血液返流时在窦区102形成涡流,利于瓣膜2的压力平衡。The structure of the sinus cavity frame 12 in this embodiment is simple and easy to manufacture. In addition, the number of structural parts of the sinus cavity frame 12 is small, and the metal coverage rate is small, so as to avoid intimal hyperplasia caused by excessive stimulation of human blood vessels. Using the sinus region 102 formed on the inner side of the sinus cavity frame 12 , a vortex can be formed in the sinus region 102 when the blood flows back, which is beneficial to the pressure balance of the valve 2 .
基于上述静脉瓣支架1的结构,再参阅图4,瓣膜2位于静脉瓣支架1的支架本体11内,对齐窦腔架12设置,并至少覆盖窦区102的一部分。瓣膜2与窦腔架12的至少部分在沿支架本体11的径向上相对,即:至少存在垂直于支架本体11中心轴的一个截面会同时穿过瓣膜2和窦腔架12。瓣膜2具有大致呈V字形的固定边缘201,固定边缘201与支架本体11或薄膜3采用例如缝合或粘接的方式固定。Based on the structure of the venous valve stent 1 , referring to FIG. 4 again, the valve 2 is located in the stent body 11 of the venous valve stent 1 , aligned with the sinus cavity frame 12 , and covers at least a part of the sinus region 102 . At least part of the valve 2 and the sinus cavity frame 12 are opposite to each other in the radial direction of the stent body 11 , that is, there is at least one cross section perpendicular to the central axis of the stent body 11 which passes through the valve 2 and the sinus cavity frame 12 at the same time. The valve 2 has a substantially V-shaped fixing edge 201, and the fixing edge 201 is fixed to the stent body 11 or the membrane 3 by, for example, suturing or bonding.
固定边缘201的V字形顶点位于窦腔架12所在的一侧,接近窦腔架12,并相对于窦腔架12更靠近远端,例如固定边缘201的V字形顶点可以是固定在远端的支撑体111的一个波峰1115上,该波峰1115位于窦腔架12所连接的两立柱112之间。The V-shaped apex of the fixed edge 201 is located on the side where the sinus cavity frame 12 is located, is close to the sinus cavity frame 12, and is closer to the distal end relative to the sinus cavity frame 12. For example, the V-shaped apex of the fixed edge 201 can be fixed at the distal end. On a wave crest 1115 of the support body 111 , the wave crest 1115 is located between the two uprights 112 to which the sinus cavity frame 12 is connected.
在由远端至近端的方向上,该固定边缘201从该V字形顶点处出发,沿着支架本体11的内壁朝向窦腔架12的对侧向近端倾斜地延伸,从而如果在图2所示的正视图上看(图 2中瓣膜2被遮挡而未示出),瓣膜2覆盖窦区102的一部分。瓣膜2在沿支架本体11的轴向上的长度例如可以是超出该窦腔架12。In the direction from the distal end to the proximal end, the fixed edge 201 starts from the apex of the V shape and extends obliquely along the inner wall of the stent body 11 toward the opposite side to the proximal end of the sinus cavity frame 12, so that if shown in FIG. 2 From the front view of (the valve 2 is obscured and not shown in FIG. 2 ), the valve 2 covers a portion of the sinus region 102 . The length of the valve 2 in the axial direction of the stent body 11 may be, for example, beyond the sinus cavity frame 12 .
瓣膜2背离窦腔架12的一侧不与支架本体11固定,因而形成自由边缘202,该自由边缘202的两端即连接在固定边缘201的V字形开口处。通过该自由边缘202的位置变化,使得瓣膜2可以封闭或打开支架本体11内的通道101。The side of the valve 2 facing away from the sinus cavity frame 12 is not fixed with the stent body 11 , so a free edge 202 is formed, and both ends of the free edge 202 are connected to the V-shaped opening of the fixed edge 201 . By changing the position of the free edge 202 , the valve 2 can close or open the channel 101 in the stent body 11 .
血液在通道101从近端流向远端的时候,血液经过窦区102,将瓣膜2推向窦腔架12对侧的支架本体11内壁,使瓣膜2的自由边缘202与支架本体11上的薄膜3贴合,血液将无法通过瓣膜2进一步向远端流动,通道101被关闭。血液从远端流向近端的时候,血液会将瓣膜2推向窦区102所在一侧,此时瓣膜2的自由边缘202与薄膜3分离,通道101被打开。需要说明的是,在瓣膜2被推向窦腔架12对侧的支架本体11内壁时,自由边缘202与薄膜3可以存在微小的间隙,此时自由边缘202不贴合于薄膜3,从而可减少自由边缘202与支架本体11或薄膜3粘合的风险,自由边缘202与薄膜3之间微小的间隙并不影响瓣膜2阻挡回流血流中的绝大部分。When the blood flows from the proximal end to the distal end of the channel 101, the blood passes through the sinus region 102 and pushes the valve 2 to the inner wall of the stent body 11 on the opposite side of the sinus cavity frame 12, so that the free edge 202 of the valve 2 and the membrane on the stent body 11 are connected. 3, the blood will not be able to flow further distally through the valve 2, and the channel 101 is closed. When blood flows from the distal end to the proximal end, the blood will push the valve 2 to the side where the sinus region 102 is located, at this time, the free edge 202 of the valve 2 is separated from the membrane 3, and the channel 101 is opened. It should be noted that when the valve 2 is pushed to the inner wall of the stent body 11 on the opposite side of the sinus cavity frame 12, there may be a slight gap between the free edge 202 and the membrane 3. At this time, the free edge 202 does not fit the membrane 3, so that the The risk of adhesion between the free edge 202 and the stent body 11 or the membrane 3 is reduced, and the small gap between the free edge 202 and the membrane 3 does not affect the valve 2 to block most of the backflow blood flow.
瓣膜2可以是包括瓣体21和瓣叶22。瓣体21构成上述固定边缘201而与静脉瓣支架1连接固定,瓣叶22连接于瓣体21之间,瓣叶22展开成平面时的面积大于该固定边缘201所围合的面积,瓣叶22未与瓣体21结合的部分边缘构成自由边缘202。瓣叶22的中间部位超出瓣体21所在的平面,瓣叶22和瓣体21之间形成一个窦腔。瓣叶22可以变形,通过瓣叶22的变形,可以使瓣叶22的自由边缘202发生位置变化,实现闭合和打开状态的切换。The valve 2 may include a valve body 21 and a valve leaflet 22 . The valve body 21 constitutes the above-mentioned fixed edge 201 and is connected and fixed with the venous valve stent 1. The valve leaflet 22 is connected between the valve bodies 21. When the valve leaflet 22 is expanded into a plane, the area is greater than the area enclosed by the fixed edge 201. The part of the edge 22 that is not combined with the valve body 21 constitutes a free edge 202 . The middle part of the valve leaflet 22 is beyond the plane where the valve body 21 is located, and a sinus cavity is formed between the valve leaflet 22 and the valve body 21 . The valve leaflet 22 can be deformed, and through the deformation of the valve leaflet 22, the position of the free edge 202 of the valve leaflet 22 can be changed, so as to realize the switching of the closed state and the open state.
基于该瓣膜2的存在,得以构建血液在通过该静脉瓣支架1时的单向通路,该瓣膜2作为单向阀使用。Based on the existence of the valve 2, a one-way passage of blood when passing through the venous valve stent 1 can be constructed, and the valve 2 is used as a one-way valve.
瓣膜2和薄膜3均由异种生物材料或者医用高分子材料制成,例如聚脂、聚四氟乙烯、聚氨脂、医用硅胶、涤纶、生物瓣膜、心包或其他可植入医用材料制成。Both the valve 2 and the membrane 3 are made of different biological materials or medical polymer materials, such as polyester, polytetrafluoroethylene, polyurethane, medical silicone, polyester, biological valve, pericardium or other implantable medical materials.
参阅图7,本实施例的静脉瓣假体100植入人体血管500时,静脉瓣支架1与血管500内膜贴合。正常情况下,血液从静脉瓣假体100的远端向近端流动并流入心脏。在一些情况下,当血液返流时,在由近端流向远端的回流血流作用下,瓣膜2在血流的冲击下朝向窦腔架12对侧运动,从而关闭支架本体11内的通道101,有效避免远端血液的返流,此时窦区102内形成的涡流使回流血流重新向近端流动,避免血液在瓣膜2根部滞留聚集,从而可以避免局部血栓的形成。Referring to FIG. 7 , when the venous valve prosthesis 100 of the present embodiment is implanted into a human blood vessel 500 , the venous valve stent 1 is attached to the intima of the blood vessel 500 . Normally, blood flows from the distal end of the venous valve prosthesis 100 to the proximal end and into the heart. In some cases, when blood flows back, the valve 2 moves toward the opposite side of the sinus cavity frame 12 under the impact of the blood flow under the action of the backflow blood flow from the proximal end to the distal end, thereby closing the channel in the stent body 11 101, effectively avoiding the backflow of blood at the distal end. At this time, the eddy current formed in the sinus region 102 makes the backflow blood flow to the proximal end again, so as to avoid blood retention and accumulation at the root of the valve 2, thereby avoiding the formation of local thrombus.
参考图8所示,在血管500内的顺流血流的流动过程中,窦区102被瓣膜2所覆盖的区域形成涡流,有利于瓣膜2的压力平衡,此时瓣膜2的瓣叶22在涡流和顺流血流的共同作用下处于悬浮状态,而不与支架本体11、薄膜3或者血管500内壁贴合,进而可以减少粘合的风险,以保证瓣膜2持续地具有单向关闭的功能,并且形成的涡流还可以避免瓣膜2根部血流滞留而形成血栓的风险。Referring to FIG. 8 , during the flow of downstream blood flow in the blood vessel 500, the area of the sinus region 102 covered by the valve 2 forms a vortex, which is beneficial to the pressure balance of the valve 2. At this time, the valve leaflet 22 of the valve 2 is in the Under the combined action of eddy current and downstream blood flow, it is in a suspended state, and does not adhere to the stent body 11, the membrane 3 or the inner wall of the blood vessel 500, thereby reducing the risk of adhesion, so as to ensure that the valve 2 continues to have a one-way closing function, In addition, the formed vortex can also avoid the risk of thrombosis due to blood flow retention at the root of the valve 2 .
基于上述的描述可知,本实施例的静脉瓣假体100中,由于在静脉瓣支架1上形成窦 区102,该窦区102的存在使得返流的血液能够在窦区102中形成涡流。在血液顺流时,基于窦区102的涡流所产生的压力平衡能够使瓣膜2在打开通道101的同时,瓣膜2的瓣叶22悬浮于通道101中而不与静脉瓣支架1或薄膜3贴合,减少瓣叶22粘合而失效的风险。并且,在存在血液返流时,血流冲击悬浮的瓣叶22相比冲击贴合静脉瓣支架1或薄膜3而言,能够更容易地使瓣膜2关闭通道101。Based on the above description, in the venous valve prosthesis 100 of the present embodiment, since the sinus region 102 is formed on the venous valve stent 1, the existence of the sinus region 102 enables the backflowing blood to form a vortex in the sinus region 102. When the blood flows downstream, the pressure balance generated by the eddy current in the sinus region 102 enables the valve 2 to open the channel 101 while the leaflets 22 of the valve 2 are suspended in the channel 101 without sticking to the venous valve stent 1 or membrane 3 This reduces the risk of failure of the valve leaflets 22 due to adhesion. In addition, when there is blood reflux, the valve 2 can more easily close the channel 101 by the blood flow impinging on the suspended valve leaflet 22 than by impinging on the venous valve stent 1 or the membrane 3 .
进一步地,静脉瓣支架1的支架本体11为可径向伸缩的结构,在植入血管500前具有较小的尺寸,手术创伤小。支架本体11在两端采用闭环结构的支撑体111,具有高径向支撑力和锚定力强的优点,在植入血管500后,可以可靠地锚定在血管500的内壁,并在周向上对血管500内膜均匀施力,减轻对血管500内膜的刺激,防止血管500内膜过度增生。而位于支架本体11中部的立柱112增加了静脉瓣支架1的轴向刚度,使负载瓣膜2的支架本体11部分不因肌肉泵、压力梯度变化等因素引起直径变化。整个静脉瓣支架1结构呈现出较大的刚性,植入后静脉瓣支架1始终保持固定形状,不因血管500透壁压的变化影响瓣膜2的瓣体21进而影响瓣叶22的功能。Further, the stent body 11 of the venous valve stent 1 is a radially expandable structure, and has a small size before being implanted into the blood vessel 500, and the surgical trauma is small. The stent body 11 adopts the support body 111 with a closed-loop structure at both ends, which has the advantages of high radial support force and strong anchoring force. Uniform force is applied to the intima of the blood vessel 500 , thereby reducing stimulation to the intima of the blood vessel 500 , and preventing excessive proliferation of the intima of the blood vessel 500 . The upright column 112 located in the middle of the stent body 11 increases the axial stiffness of the venous valve stent 1, so that the stent body 11 part of the load valve 2 does not change in diameter due to factors such as muscle pump and pressure gradient changes. The entire structure of the venous valve stent 1 exhibits greater rigidity, and the venous valve stent 1 always maintains a fixed shape after implantation, and does not affect the valve body 21 of the valve 2 and thus the function of the valve leaflets 22 due to changes in the transmural pressure of the blood vessel 500 .
静脉瓣支架1的窦腔架12在支架本体11侧部形成窦区102,形成符合流体力学的结构优势,使血液在瓣膜2处不产生血栓。特别地,窦腔架12采用具有悬空的自由端1203的设计而在径向上具有弹性,可以避免窦腔架12对血管500的过度刺激。并且在植入人体后,由于自由端1203是悬空的,相比窦腔架12更靠近近端的支撑体111不会对自由端1203形成约束,窦腔架12可以更容易保持为至少部分外凸于支架本体11的结构形式,从而维持窦区102的稳定性。The sinus cavity frame 12 of the venous valve stent 1 forms a sinus region 102 on the side of the stent body 11 , forming a structural advantage in line with hydrodynamics, so that blood does not generate thrombus at the valve 2 . In particular, the sinus cavity frame 12 adopts a design with a suspended free end 1203 to have elasticity in the radial direction, which can avoid excessive stimulation of the blood vessel 500 by the sinus cavity frame 12 . And after implantation into the human body, since the free end 1203 is suspended, the support body 111 closer to the proximal end of the sinus cavity frame 12 will not constrain the free end 1203, and the sinus cavity frame 12 can be more easily maintained at least partially outside. Convex the structural form of the stent body 11 , thereby maintaining the stability of the sinus region 102 .
同时,本实施例的窦腔架12由第一支杆121和第二支杆122连接于支架本体11上而形成,结构件少,结构简单。在实际制作时,可以先分别制作支架本体11和窦腔架12,再将两者连接为一体,制作方便。另外,窦腔架12与立柱112相连,结构简单的窦腔架12配合间隔布置的立柱112,使得静脉瓣支架1还具有较大的操作空间供瓣膜2连接,并且金属覆盖率小,有效减轻对血管500内膜的刺激。Meanwhile, the sinus cavity frame 12 of this embodiment is formed by connecting the first support rod 121 and the second support rod 122 to the support body 11 , with few structural parts and a simple structure. In actual manufacture, the stent body 11 and the sinus cavity frame 12 can be manufactured separately first, and then the two are connected as a whole, which is convenient for manufacture. In addition, the sinus cavity frame 12 is connected with the upright post 112, and the sinus cavity frame 12 with a simple structure is matched with the upright posts 112 arranged at intervals, so that the venous valve stent 1 also has a large operating space for the connection of the valve 2, and the metal coverage rate is small, which effectively reduces the Stimulation of blood vessel 500 intima.
可以理解的是,在其他未示出的结构中,窦腔架12也并不限于采用本实施例中由第一支杆121和第二支杆122组成的结构形式。基于本发明的构思,窦腔架12只需满足下述条件:其一端为固定端与支架本体11固定连接,相对的另一端为悬空设置的自由端1203,窦腔架12至少部分在支架本体11的径向上向外凸出于支架本体11而在窦腔架12的内侧形成窦区102。其中,本实施例中,第一支杆121的近端端部和第二支杆122的近端端部分别连接支架本体11的部位即构成固定端。事实上,由于窦腔架12一端固定,另一端为自由端,窦腔架12的整体结构形状不受支架本体11或者具体而言不受支架本体11的开窗115的约束,因此,可以根据实际情况灵活地设置窦腔架12的结构形式,方便窦腔架12的制作以及与支架本体11的连接。It can be understood that, in other structures not shown, the sinus cavity frame 12 is not limited to adopt the structural form composed of the first strut 121 and the second strut 122 in this embodiment. Based on the concept of the present invention, the sinus cavity frame 12 only needs to meet the following conditions: one end is a fixed end that is fixedly connected to the bracket body 11 , the opposite end is a free end 1203 that is suspended in the air, and the sinus cavity frame 12 is at least partially in the bracket body. The radial direction of 11 protrudes outward from the stent body 11 to form a sinus region 102 on the inner side of the sinus cavity frame 12 . Wherein, in this embodiment, the portions where the proximal end portion of the first support rod 121 and the proximal end portion of the second support rod 122 are respectively connected to the bracket body 11 constitute fixed ends. In fact, since one end of the sinus cavity frame 12 is fixed and the other end is a free end, the overall structural shape of the sinus cavity frame 12 is not constrained by the stent body 11 or specifically the fenestration 115 of the stent body 11 . In practice, the structural form of the sinus cavity frame 12 is flexibly set, which facilitates the manufacture of the sinus cavity frame 12 and the connection with the stent body 11 .
本实施例的该静脉瓣支架1可采用镍钛合金激光雕刻制作。在一些实施例中,静脉瓣支架1的总长度L1(不计显影杆1112的长度)可为15mm~30mm,支撑体111的直径 D1可为5mm~30mm,窦腔架12所在处最大直径D2比支撑体111的直径D1突出2.5mm。The venous valve stent 1 in this embodiment can be manufactured by laser engraving of NiTi alloy. In some embodiments, the total length L1 of the venous valve stent 1 (excluding the length of the developing rod 1112 ) may be 15 mm˜30 mm, the diameter D1 of the support body 111 may be 5 mm˜30 mm, and the maximum diameter D2 where the sinus cavity frame 12 is located is smaller than The diameter D1 of the support body 111 protrudes by 2.5 mm.
静脉瓣支架1杆厚可设计为0.35mm,支撑体111中每根杆宽可设计为0.35mm,立柱112和窦腔架12中每根杆宽可设计为0.6mm,使静脉瓣支架1有更好的径向支撑力和轴向刚度。The thickness of the venous valve stent 1 can be designed to be 0.35mm, the width of each rod in the support body 111 can be designed to be 0.35mm, and the width of each rod in the upright post 112 and the sinus cavity frame 12 can be designed to be 0.6mm, so that the venous valve stent 1 has Better radial support and axial stiffness.
第二实施例,参阅图9至图12所示的结构。For the second embodiment, refer to the structures shown in FIGS. 9 to 12 .
本实施例的静脉瓣假体100a相比于第一实施例的不同之处在于:静脉瓣假体100a的静脉瓣支架1a具有多个窦区102a,本实施例中,窦区102a为两个。对应地,瓣膜2a为双瓣结构。薄膜3a覆盖到两个窦区102a。The difference between the venous valve prosthesis 100a of this embodiment and the first embodiment is that the venous valve stent 1a of the venous valve prosthesis 100a has a plurality of sinus regions 102a, and in this embodiment, there are two sinus regions 102a . Correspondingly, the valve 2a has a double valve structure. The membrane 3a covers the two sinus regions 102a.
静脉瓣支架1a中具有相对设置的两个窦腔架12a,两窦腔架12a分别相对于支架本体11a向外凸出,从而两个窦区102a的方向也是相对。The venous valve stent 1a has two sinus cavity frames 12a disposed opposite to each other, and the two sinus cavity frames 12a respectively protrude outward relative to the stent body 11a, so that the directions of the two sinus regions 102a are also opposite.
两个瓣膜2a缝制于两个窦腔架12a之间。两个瓣膜2a的自由边缘202a在静脉瓣支架1a的中部相接。The two valves 2a are sewn between the two sinus frames 12a. The free edges 202a of the two valves 2a meet in the middle of the venous valve stent 1a.
血液返流时,两个瓣膜2a拱起,两个瓣膜2a的自由边缘202a贴合在一起,封闭通道101a,阻止返流血液通过。两个窦区102a内分别形成涡流,促使血液重新回到近端,避免血液积累。When blood flows back, the two valves 2a are arched, and the free edges 202a of the two valves 2a are abutted together to close the channel 101a and prevent the backflow blood from passing through. Eddy currents are formed in the two sinus regions 102a, respectively, so as to promote blood to return to the proximal end and avoid blood accumulation.
顺流血液通过时,血流冲击瓣膜2a,两个瓣膜2a的自由边缘202a相分离,打开通道101a使血液正常流到近端。When the downstream blood passes through, the blood flow impacts the valve 2a, the free edges 202a of the two valves 2a are separated, and the channel 101a is opened to allow the blood to flow to the proximal end normally.
本实施例中,采用两个窦腔架12a的结构,有效平衡瓣膜2a开张状态,在静脉瓣支架1a的两侧均形成涡流,避免血液积累引起局部血栓。In this embodiment, the structure of two sinus cavity stents 12a is adopted to effectively balance the open state of the valve 2a, and eddy currents are formed on both sides of the venous valve stent 1a to avoid local thrombosis caused by blood accumulation.
相比于第一实施例的四根立柱112,本实施例中,未连接窦腔架12a的两个立柱112a之间的间隔内还额外设置了一根立柱112a,即本实施例的支架本体11a总共具有六根立柱112a,增大了径向支撑强度。当然,在径向支撑强度足够时,该多出的两根立柱112a也可以省略。Compared with the four uprights 112 in the first embodiment, in this embodiment, an additional upright 112a is provided in the interval between the two uprights 112a that are not connected to the sinus cavity frame 12a, that is, the stent body of this embodiment 11a has a total of six uprights 112a, increasing the radial support strength. Of course, when the radial support strength is sufficient, the extra two uprights 112a can also be omitted.
该第二实施例以双瓣为例进行说明,基于本发明的构思,静脉瓣假体还可以具有三个及以上的窦区,相应地,窦腔架对应地设置为三个及以上,瓣膜也对应地为三瓣及多瓣结构。The second embodiment is described by taking a double valve as an example. Based on the concept of the present invention, the venous valve prosthesis can also have three or more sinus regions. Correspondingly, there are three-lobed and multi-lobed structures.
第三实施例,参阅图13和图14所示的结构。For the third embodiment, refer to the structures shown in FIGS. 13 and 14 .
本实施例是上述第二实施例的进一步扩展,本实施例的静脉瓣假体100b中,静脉瓣支架1b设有四个窦腔架12b,四个窦腔架12b沿静脉瓣支架1b周向均匀分布,分别设置于相邻两个立柱112a之间。相应地,在该静脉瓣支架1b中形成四个窦区102b。瓣膜2b的数量也对应为四个,一一相对于窦区102b设置。This embodiment is a further extension of the above-mentioned second embodiment. In the venous valve prosthesis 100b of this embodiment, the venous valve stent 1b is provided with four sinus cavity frames 12b, and the four sinus cavity frames 12b are along the circumferential direction of the venous valve stent 1b Evenly distributed, they are respectively arranged between two adjacent uprights 112a. Accordingly, four sinus regions 102b are formed in the venous valve stent 1b. The number of valves 2b is also corresponding to four, which are arranged one by one relative to the sinus region 102b.
第四实施例,参阅图15和图16所示的结构。For the fourth embodiment, refer to the structures shown in FIGS. 15 and 16 .
本实施例的静脉瓣假体100c相比于第一实施例的不同之处在于静脉瓣支架1c的窦腔架12c的结构不同。The venous valve prosthesis 100c of this embodiment is different from the first embodiment in that the structure of the sinus cavity frame 12c of the venous valve stent 1c is different.
本实施例中,窦腔架12c的自由端1203c不朝向支架本体11c内侧弯曲,取而代之的 是:窦腔架12c在沿支架本体11c轴向上划分为靠近远端的第一延伸段1201c和靠近近端的第二延伸段1202c,在由远端至近端的方向上,第一延伸段1201c到支架本体11c的中心轴L的距离逐渐变大,第二延伸段1202c到中心轴L的距离保持不变,如图16所示意的在穿过中心轴L和自由端1203c的一平面上看,第二延伸段1202c在该平面上的投影平行于中心轴L。In this embodiment, the free end 1203c of the sinus cavity frame 12c is not bent toward the inner side of the stent body 11c, instead, the sinus cavity frame 12c is divided into a first extension section 1201c near the distal end and a first extension section 1201c near the distal end along the axial direction of the stent body 11c. For the second extension section 1202c at the proximal end, in the direction from the distal end to the proximal end, the distance from the first extension section 1201c to the central axis L of the stent body 11c gradually increases, and the distance from the second extension section 1202c to the central axis L remains constant. 16, viewed on a plane passing through the central axis L and the free end 1203c, the projection of the second extension 1202c on the plane is parallel to the central axis L.
本实施例中,窦腔架12c的自由端1203c在沿支架本体11c径向上依然不超出窦腔架12c除自由端1203c以外剩余部分的最外侧部位1204c。In this embodiment, the free end 1203c of the sinus cavity frame 12c still does not extend beyond the outermost portion 1204c of the remaining part of the sinus cavity frame 12c except for the free end 1203c in the radial direction of the stent body 11c.
该第二延伸段1202c到中心轴L的距离保持不变,在静脉瓣假体100c植入人体血管时,通过该第二延伸段1202c可以避免血管壁局部应力集中,缓解窦腔架12c外凸对血管壁造成的压力,避免血管壁由于局部应力集中而承受过大的压力。The distance from the second extension section 1202c to the central axis L remains unchanged. When the venous valve prosthesis 100c is implanted into a human blood vessel, the second extension section 1202c can avoid local stress concentration on the blood vessel wall and relieve the convexity of the sinus cavity frame 12c The pressure on the blood vessel wall to avoid excessive pressure on the blood vessel wall due to local stress concentration.
第五实施例,参阅图17和图18所示的结构。For the fifth embodiment, refer to the structures shown in FIGS. 17 and 18 .
本实施例的静脉瓣假体100d相比于第一实施例的不同之处在于静脉瓣支架1d的窦腔架12d的结构不同。The difference between the venous valve prosthesis 100d of the present embodiment and the first embodiment is that the structure of the sinus cavity frame 12d of the venous valve stent 1d is different.
本实施例中,窦腔架12d还包括横杆123d,第一支杆121d与第二支架122d通过横杆123d相连接;横杆123d沿支架本体11d的周向延伸,横杆123d的两端分别连接第一支杆121d的近端端部和第二支杆122d的近端端部。In this embodiment, the sinus cavity frame 12d further includes a cross bar 123d. The first support bar 121d and the second support 122d are connected by the cross bar 123d. The cross bar 123d extends along the circumferential direction of the support body 11d. The proximal end portion of the first strut 121d and the proximal end portion of the second strut 122d are respectively connected.
该横杆123d的设置可以增加薄膜3d的支撑面积,确保薄膜3d覆盖窦区的部分在涡流冲击下的牢固性能。且横杆123d可以削弱窦腔架12d的自由端的尖锐程度,通过其横向面积的增加可以避免植入时对血管壁的损伤。The arrangement of the cross bar 123d can increase the supporting area of the membrane 3d, and ensure the firm performance of the part of the membrane 3d covering the sinus area under the impact of eddy currents. In addition, the transverse rod 123d can weaken the sharpness of the free end of the sinus cavity frame 12d, and the increase of the transverse area thereof can avoid damage to the vessel wall during implantation.
第六实施例,参阅图19至图21所示的结构。For the sixth embodiment, refer to the structures shown in FIGS. 19 to 21 .
本实施例的静脉瓣假体100e相比于第一实施例的不同之处在于静脉瓣支架1e中窦腔架12e与支架本体11e的连接位置不同。The venous valve prosthesis 100e of this embodiment is different from the first embodiment in that the connection position of the sinus cavity frame 12e and the stent body 11e in the venous valve stent 1e is different.
本实施例中,窦腔架12e的第一支杆121e和第二支杆122e不连接到立柱112e的端部,而是连接立柱112e的中间区域。In this embodiment, the first strut 121e and the second strut 122e of the sinus cavity frame 12e are not connected to the ends of the upright post 112e, but are connected to the middle area of the upright post 112e.
其中,窦腔架12e的自由端1203e距靠近近端的支撑体111e之间具有距离S1,第一支杆121e的近端端部和第二支杆122e的近端端部距靠近远端的支撑体111e具有距离S2,本实施例中,S1与S2相等。Wherein, there is a distance S1 between the free end 1203e of the sinus cavity frame 12e and the support body 111e near the proximal end, and the proximal end of the first strut 121e and the proximal end of the second strut 122e are separated from the proximal end of the first strut 121e The support body 111e has a distance S2, and in this embodiment, S1 and S2 are equal.
第七实施例,参阅图22和图23所示的结构。For the seventh embodiment, refer to the structures shown in FIG. 22 and FIG. 23 .
本实施例的静脉瓣假体100f相比第一实施例的不同之处在于静脉瓣支架1f的支架本体11f的结构不同。The venous valve prosthesis 100f of this embodiment is different from the first embodiment in that the structure of the stent body 11f of the venous valve stent 1f is different.
本实施例中,支架本体11f为一体式网状支架,其整个外周壁均呈网状,而不再具有如第一实施例的立柱112。该支架本体11f的侧部开设大致呈矩形的缺口而形成开窗115f,该开窗115f在沿支架本体11f轴向上位于该支架本体11f的中部区域。窦腔架12f设置于该开窗115f处。In this embodiment, the support body 11f is an integrated mesh support, and the entire outer peripheral wall thereof is mesh-shaped, and no longer has the upright column 112 as in the first embodiment. A substantially rectangular notch is formed on the side of the bracket body 11f to form a window 115f, and the window 115f is located in the middle area of the bracket body 11f in the axial direction of the bracket body 11f. The sinus cavity frame 12f is provided at the opening 115f.
该支架本体11f包括多个环形的波形圈1111f,多个环形的波形圈1111f沿支架本体 11f的轴线依次设置并轴向相接形成网格。而开窗115f可以通过在支架本体11f上经切割形成。The support body 11f includes a plurality of annular wave rings 1111f, and the plurality of annular wave rings 1111f are arranged in sequence along the axis of the support body 11f and axially connect to form a grid. And the opening 115f may be formed by cutting on the bracket body 11f.
本实施例采用一体式网状结构的支架本体11f,具有较好的径向收缩和扩张性能。而支架本体11f侧部所设置的开窗115f能够提高静脉瓣支架1f整体的柔顺性能。静脉瓣支架1f在开窗115f处可以弯折,使其能够更容易地通过迂回复杂的血管通路,相比第一实施例还具有更高的灵活性。This embodiment adopts the stent body 11f of an integrated mesh structure, which has better radial contraction and expansion performance. The window 115f provided on the side of the stent body 11f can improve the overall compliance performance of the venous valve stent 1f. The venous valve stent 1f can be bent at the fenestration 115f, so that it can pass through the circuitous and complicated vascular access more easily, and has higher flexibility than the first embodiment.
虽然已参照几个典型实施方式描述了本发明,但应当理解,所用的术语是说明和示例性、而非限制性的术语。由于本发明能够以多种形式具体实施而不脱离发明的精神或实质,所以应当理解,上述实施方式不限于任何前述的细节,而应在随附权利要求所限定的精神和范围内广泛地解释,因此落入权利要求或其等效范围内的全部变化和改型都应为随附权利要求所涵盖。While the present invention has been described with reference to several exemplary embodiments, it is to be understood that the terminology used is of description and illustration, and not of limitation. Since the invention can be embodied in many forms without departing from the spirit or spirit of the invention, it is to be understood that the above-described embodiments are not limited to any of the foregoing details, but are to be construed broadly within the spirit and scope defined by the appended claims Therefore, all changes and modifications that come within the scope of the claims or their equivalents should be covered by the appended claims.

Claims (25)

  1. 一种静脉瓣支架,其特征在于,包括:A venous valve stent, comprising:
    支架本体,其呈中空的筒状结构且可径向伸缩;该支架本体的侧部设有至少一个开窗;及a bracket body, which has a hollow cylindrical structure and can be radially extended and retracted; at least one opening window is provided on the side of the bracket body; and
    至少一个窦腔架,对应于所述至少一个开窗设置;每一窦腔架具有相对的固定端和自由端;所述固定端连接于对应的一所述开窗的边缘;所述自由端悬空设置;所述窦腔架的至少部分在所述支架本体的径向上向外凸出于所述支架本体;所述窦腔架的内侧形成窦区,所述窦区经所述开窗与所述支架本体内部相通。At least one sinus cavity frame is disposed corresponding to the at least one fenestration; each sinus cavity frame has opposite fixed ends and free ends; the fixed end is connected to a corresponding edge of the fenestration; the free end Suspended setting; at least part of the sinus cavity frame protrudes outward from the stent body in the radial direction of the stent body; the inner side of the sinus cavity frame forms a sinus area, and the sinus area is connected to the fenestration through the fenestration. The inside of the bracket body is communicated.
  2. 根据权利要求1所述的静脉瓣支架,其特征在于,在沿所述支架本体径向上,所述自由端不超出所述窦腔架除所述自由端以外剩余部分的最外侧部位。The venous valve stent according to claim 1, wherein in the radial direction of the stent body, the free end does not exceed the outermost part of the remaining part of the sinus cavity frame except the free end.
  3. 根据权利要求2所述的静脉瓣支架,其特征在于,所述窦腔架包括第一延伸段和第二延伸段,所述第二延伸段通过所述第一延伸段连接所述支架本体,所述第一延伸段与所述第二延伸段连接的部位形成所述窦腔架的最外侧部位,所述第二延伸段的末端形成所述自由端,所述第一延伸段与所述支架本体连接的部位形成所述固定端,所述最外侧部位与所述支架本体的中心轴之间的距离大于所述固定端与所述支架本体的中心轴之间的距离。The venous valve stent according to claim 2, wherein the sinus cavity stent comprises a first extension section and a second extension section, and the second extension section is connected to the stent body through the first extension section, The part where the first extension section and the second extension section are connected forms the outermost part of the sinus cavity frame, the end of the second extension section forms the free end, and the first extension section and the The part where the bracket body is connected forms the fixed end, and the distance between the outermost part and the central axis of the bracket body is greater than the distance between the fixed end and the central axis of the bracket body.
  4. 根据权利要求3所述的静脉瓣支架,其特征在于,所述自由端与所述支架本体的中心轴之间的距离小于所述最外侧部位与所述支架本体的中心轴之间的距离。The venous valve stent according to claim 3, wherein the distance between the free end and the central axis of the stent body is smaller than the distance between the outermost part and the central axis of the stent body.
  5. 根据权利要求4所述的静脉瓣支架,其特征在于,所述第二延伸段呈曲线弯曲延伸,且曲线往背离所述支架本体的方向凸出。The venous valve stent according to claim 4, wherein the second extension section extends in a curved manner, and the curve protrudes in a direction away from the stent body.
  6. 根据权利要求4所述的静脉瓣支架,其特征在于,所述第二延伸段呈直线状延伸。The venous valve stent according to claim 4, wherein the second extension section extends linearly.
  7. 根据权利要求3所述的静脉瓣支架,其特征在于,在穿过所述中心轴和所述自由端的平面上看,所述第二延伸段在该平面上的投影与所述中心轴平行。The venous valve stent according to claim 3, wherein, viewed on a plane passing through the central axis and the free end, the projection of the second extending section on the plane is parallel to the central axis.
  8. 根据权利要求3所述的静脉瓣支架,其特征在于,所述第一延伸段呈曲线弯曲延伸,且曲线往背离所述支架本体的方向凸出。The venous valve stent according to claim 3, wherein the first extension section extends in a curved manner, and the curve protrudes in a direction away from the stent body.
  9. 根据权利要求3所述的静脉瓣支架,其特征在于,所述第一延伸段呈直线状延伸。The venous valve stent according to claim 3, wherein the first extension section extends linearly.
  10. 根据权利要求1所述的静脉瓣支架,其特征在于,所述窦腔架包括第一支杆和连接所述第一支杆的第二支杆,所述第一支杆和所述第二支杆分别连接所述支架本体,所述第一支杆和所述第二支杆分别连接所述支架本体的部位形成所述固定端,所述第一支杆和所述第二支杆连接的部位形成所述自由端。The venous valve stent according to claim 1, wherein the sinus cavity stent comprises a first strut and a second strut connected to the first strut, the first strut and the second strut The support rods are respectively connected to the bracket body, the parts where the first support rod and the second support rod are respectively connected to the support body form the fixed end, and the first support rod and the second support rod are connected The part forms the free end.
  11. 根据权利要求10所述的静脉瓣支架,其特征在于,所述第一支杆和所述第二支杆直接连接。The venous valve stent according to claim 10, wherein the first strut and the second strut are directly connected.
  12. 根据权利要求10所述的静脉瓣支架,其特征在于,所述窦腔架还包括横杆,所述第一支杆和所述第二支杆通过所述横杆连接。The venous valve stent according to claim 10, wherein the sinus cavity stent further comprises a cross bar, and the first strut and the second strut are connected by the cross bar.
  13. 根据权利要求12所述的静脉瓣支架,其特征在于,所述第一支杆和所述支架本 体连接的部位与所述第二支杆和所述支架本体连接的部位之间的距离,大于所述第一支杆和所述横杆连接的部位与所述第二支杆和所述横杆连接的部位之间的距离。The venous valve stent according to claim 12, wherein the distance between the part where the first strut is connected to the stent body and the part where the second strut is connected to the stent body is greater than The distance between the part where the first support rod and the cross rod are connected and the part where the second support rod and the cross rod are connected.
  14. 根据权利要求10所述的静脉瓣支架,其特征在于,所述第一支杆和所述第二支杆之间的夹角为30°~90°。The venous valve stent according to claim 10, wherein the included angle between the first strut and the second strut is 30°˜90°.
  15. 根据权利要求10所述的静脉瓣支架,其特征在于,所述第一支杆和所述第二支杆对称。The venous valve stent according to claim 10, wherein the first strut and the second strut are symmetrical.
  16. 根据权利要求1-15任一项所述的静脉瓣支架,其特征在于,至少一个所述开窗位于所述支架本体轴向的中部区域。The venous valve stent according to any one of claims 1-15, characterized in that, at least one of the fenestrations is located in the axial middle region of the stent body.
  17. 根据权利要求16所述的静脉瓣支架,其特征在于,所述窦腔架在沿所述支架本体轴向上的长度大于对应的所述开窗在沿所述支架本体轴向上的长度的一半。The venous valve stent according to claim 16, wherein the length of the sinus cavity frame in the axial direction of the stent body is greater than the length of the corresponding fenestration in the axial direction of the stent body. half.
  18. 根据权利要求16所述的静脉瓣支架,其特征在于,所述支架本体包括至少两个支撑体和多个立柱,每个所述立柱连接间隔的两个所述支撑体,所述开窗由所述支撑体和所述立柱合围成。The venous valve stent according to claim 16, wherein the stent body comprises at least two support bodies and a plurality of uprights, each of the uprights is connected to the two spaced apart support bodies, and the window is formed by The support body and the upright column are enclosed.
  19. 根据权利要求18所述的静脉瓣支架,其特征在于,每个所述支撑体包括轴向相接的多个波形圈;每个波形圈沿周向具有相交错的波峰和波谷,在相邻两个波形圈中,其中一个所述波形圈的波峰与另一个所述波形圈的波谷连接形成网格状。The venous valve stent according to claim 18, wherein each of the supporting bodies comprises a plurality of corrugated circles that are connected in the axial direction; Among the two wave circles, the wave crest of one of the wave circles is connected with the wave trough of the other wave circle to form a grid shape.
  20. 根据权利要求19所述的静脉瓣支架,其特征在于,其中一个所述支撑体的波峰通过所述立柱连接另一个所述支撑体的波谷。The venous valve stent according to claim 19, wherein the wave crest of one support body is connected to the wave trough of the other support body through the post.
  21. 根据权利要求18所述的静脉瓣支架,其特征在于,所述立柱呈直线状,且沿所述支架本体的轴向延伸。The venous valve stent according to claim 18, wherein the upright column is linear and extends along the axial direction of the stent body.
  22. 根据权利要求16所述的静脉瓣支架,其特征在于,所述支架本体为一体结构,其整个外周壁均呈网状,所述外周壁上开设至少一个所述开窗。The venous valve stent according to claim 16, wherein the stent body is an integral structure, the entire peripheral wall thereof is in the shape of a mesh, and at least one of the fenestrations is provided on the peripheral wall.
  23. 根据权利要求1-15任一项所述的静脉瓣支架,其特征在于,所述开窗的数量为多个,多个所述开窗沿所述支架本体周向分布;所述窦腔架设有多个,一一对应连接于所述开窗的边缘。The venous valve stent according to any one of claims 1-15, wherein the number of the fenestrations is multiple, and the multiple fenestrations are distributed along the circumference of the stent body; the sinus cavity is erected There are a plurality of them, which are connected to the edge of the window in one-to-one correspondence.
  24. 一种静脉瓣假体,其特征在于,包括瓣膜以及如权利要求1-23任一项所述的静脉瓣支架;所述瓣膜固定于所述支架本体内,所述瓣膜与所述窦腔架的至少部分在所述支架本体的径向上相对;所述瓣膜具有自由边缘,所述自由边缘位于所述瓣膜背离所述窦腔架的一侧。A venous valve prosthesis, characterized in that it comprises a valve and the venous valve stent according to any one of claims 1-23; the valve is fixed in the stent body, and the valve is connected to the sinus cavity frame At least part of the valve is opposite in the radial direction of the stent body; the valve has a free edge, the free edge is located on the side of the valve away from the sinus cavity frame.
  25. 根据权利要求24所述的静脉瓣假体,其特征在于,所述静脉瓣假体还包括薄膜,所述薄膜覆盖所述静脉瓣支架的整个周壁。The venous valve prosthesis according to claim 24, wherein the venous valve prosthesis further comprises a membrane covering the entire peripheral wall of the venous valve stent.
PCT/CN2021/117438 2020-09-29 2021-09-09 Venous valve stent and venous valve prosthesis WO2022068550A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202011049137.8A CN114305795A (en) 2020-09-29 2020-09-29 Venous valve support and venous valve prosthesis
CN202011049137.8 2020-09-29
CN202022196520.8 2020-09-29
CN202022196520.8U CN212234805U (en) 2020-09-29 2020-09-29 Venous valve support and venous valve prosthesis

Publications (1)

Publication Number Publication Date
WO2022068550A1 true WO2022068550A1 (en) 2022-04-07

Family

ID=80951181

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/117438 WO2022068550A1 (en) 2020-09-29 2021-09-09 Venous valve stent and venous valve prosthesis

Country Status (1)

Country Link
WO (1) WO2022068550A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106821547A (en) * 2015-12-03 2017-06-13 美敦力心血管股份有限公司 Vein valve prosthese
CN109069268A (en) * 2016-02-08 2018-12-21 伊诺文蒂克有限公司 The treatment of tricuspid insufficiency
US20190029814A1 (en) * 2013-10-23 2019-01-31 Caisson Interventional, LLC Methods and Systems for Heart Valve Therapy
CN110236733A (en) * 2019-07-18 2019-09-17 南京市儿童医院 A kind of novel valved conduit and preparation method thereof
CN212234805U (en) * 2020-09-29 2020-12-29 杭州诺谊医疗科技有限公司 Venous valve support and venous valve prosthesis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190029814A1 (en) * 2013-10-23 2019-01-31 Caisson Interventional, LLC Methods and Systems for Heart Valve Therapy
CN106821547A (en) * 2015-12-03 2017-06-13 美敦力心血管股份有限公司 Vein valve prosthese
CN109069268A (en) * 2016-02-08 2018-12-21 伊诺文蒂克有限公司 The treatment of tricuspid insufficiency
CN110236733A (en) * 2019-07-18 2019-09-17 南京市儿童医院 A kind of novel valved conduit and preparation method thereof
CN212234805U (en) * 2020-09-29 2020-12-29 杭州诺谊医疗科技有限公司 Venous valve support and venous valve prosthesis

Similar Documents

Publication Publication Date Title
ES2860600T3 (en) Articulated commissure valve endoprosthesis
EP1631218B1 (en) Prosthetic valve with vessel engaging member
EP3220856B1 (en) Heart valve prosthesis
US10226344B2 (en) Percutaneous valve, system and method
AU2002334045B2 (en) Assembly for setting a valve prosthesis in a corporeal duct
JP4989684B2 (en) Valve assembly for use in a lumen of a vessel and method for making the valve assembly
JP5250046B2 (en) Percutaneous heart valve, system, and method
US20080091261A1 (en) Implantable valve prosthesis
US9775704B2 (en) Implantable valve prosthesis
EP3711716A1 (en) Valve stent, valve prosthesis and delivery device
US20040193253A1 (en) Replacement venous valve
US20100114300A1 (en) Medical device with leak path
WO2011079803A1 (en) Invasive cardiac valve
KR102563467B1 (en) Pulmonary ball valve assembly via catheter
KR20210005144A (en) Mechanically expandable heart valve with leaflet clamp
CN212234805U (en) Venous valve support and venous valve prosthesis
CN203379235U (en) Pulmonary artery support and pulmonary artery valve replacement device with thereof
WO2022068550A1 (en) Venous valve stent and venous valve prosthesis
CN216318216U (en) Clamping and positioning device for interventional valve and artificial valve system
US20210228385A1 (en) Prosthetic vascular valve and methods associated therewith
CN212630964U (en) Interventional venous valve support and venous valve prosthesis
CN114305795A (en) Venous valve support and venous valve prosthesis
CN218870588U (en) Valve leaf mounting structure and artificial venous valve
CN216257645U (en) Backflow prevention type artificial aortic valve anchoring part
US20230372103A1 (en) Venous Valve Prosthesis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21874211

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21874211

Country of ref document: EP

Kind code of ref document: A1